| 1 | N | N | N | Etretinate
 | RORB: RAR-related orphan receptor B | 0.37143 | Tretinoin
 | 0.17888 | RARB: retinoic acid receptor, beta |
| 9 | N | N | N | Tazarotene
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.14634 | Tretinoin
 | 0.070957 | RXRA: retinoid X receptor, alpha |
| 25 | N | N | N | Etretinate
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.37143 | Tretinoin
 | 0.070957 | RXRA: retinoid X receptor, alpha |
| 31 | N | N | N | Tretinoin
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.21951 | Chenodiol
 | 0.19755 | RARB: retinoic acid receptor, beta |
| 34 | N | N | N | Etretinate
 | RORC: RAR-related orphan receptor C | 0.37143 | Tretinoin
 | 0.13240 | RARB: retinoic acid receptor, beta |
| 38 | N | N | N | Chenodiol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.48718 | Calcitriol
 | 0.20226 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 42 | Y | N | N | Eplerenone
 | PGR: progesterone receptor | 0.48718 | Medroxyprogesterone acetate
 | 0.23099 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 44 | N | N | N | Diethylstilbestrol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.23333 | Phenobarbital
 | 0.16999 | ESRRA: estrogen-related receptor alpha |
| 45 | N | N | N | Mometasone furoate
 | ESR1: estrogen receptor 1 | 0.47500 | Fluoxymesterone
 | 0.12952 | PGR: progesterone receptor |
| 47 | N | N | N | Diethylstilbestrol
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.085714 | Palmitic acid
 | 0.19965 | ESRRG: estrogen-related receptor gamma |
| 49 | N | N | N | Tazarotene
 | ESR1: estrogen receptor 1 | 0.40625 | Diethylstilbestrol
 | 0.18294 | RXRA: retinoid X receptor, alpha |
| 57 | N | N | N | Tretinoin
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.054054 | Phenobarbital
 | 0.18237 | RARG: retinoic acid receptor, gamma |
| 62 | N | N | N | Diethylstilbestrol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.45161 | Fenofibrate
 | 0.14241 | ESRRG: estrogen-related receptor gamma |
| 64 | N | N | N | Estrone
 | PGR: progesterone receptor | 0.44828 | Norethindrone
 | 0.12952 | ESR1: estrogen receptor 1 |
| 67 | N | N | N | Tazarotene
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.42857 | Fenofibrate
 | 0.21233 | RARB: retinoic acid receptor, beta |
| 68 | N | N | N | Tretinoin
 | ESRRA: estrogen-related receptor alpha | 0.076923 | Diethylstilbestrol
 | 0.23672 | RXRA: retinoid X receptor, alpha |
| 70 | N | N | N | Diethylstilbestrol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.090909 | Chenodiol
 | 0.15388 | ESRRG: estrogen-related receptor gamma |
| 72 | N | N | N | Tretinoin
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10909 | Telmisartan
 | 0.20203 | RARB: retinoic acid receptor, beta |
| 74 | N | N | N | Estrone sodium sulfate
 | PGR: progesterone receptor | 0.35714 | Mifepristone
 | 0.12952 | ESR1: estrogen receptor 1 |
| 75 | N | N | N | Tretinoin
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.34210 | Ergocalciferol
 | 0.18311 | RARG: retinoic acid receptor, gamma |
| 78 | N | N | N | Tretinoin
 | ESRRB: estrogen-related receptor beta | 0.076923 | Diethylstilbestrol
 | 0.23259 | RXRA: retinoid X receptor, alpha |
| 81 | N | N | N | Diethylstilbestrol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.29268 | Rosiglitazone maleate
 | 0.14244 | ESRRG: estrogen-related receptor gamma |
| 83 | N | N | N | Tretinoin
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.093023 | Fenofibrate
 | 0.21233 | RARB: retinoic acid receptor, beta |
| 87 | N | N | N | Diethylstilbestrol
 | RXRB: retinoid X receptor, beta | 0.40625 | Tazarotene
 | 0.21699 | ESRRA: estrogen-related receptor alpha |
| 89 | N | N | N | Isotretinoin
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.34210 | Ergocalciferol
 | 0.17498 | RARA: retinoic acid receptor, alpha |
| 90 | N | N | N | Tazarotene
 | ESR2: estrogen receptor 2 (ER beta) | 0.40625 | Diethylstilbestrol
 | 0.16853 | RXRA: retinoid X receptor, alpha |
| 94 | N | N | N | Nandrolone phenpropionate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.47619 | Mifepristone
 | 0.23366 | AR: androgen receptor |
| 95 | N | N | N | Chenodiol
 | ESR1: estrogen receptor 1 | 0.45714 | Progesterone
 | 0.11758 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 102 | N | N | N | Imatinib mesilate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.37288 | Telmisartan
 | 0.17144 | RORA: RAR-related orphan receptor A |
| 103 | N | N | N | Palmitic acid
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.15909 | Rosiglitazone maleate
 | 0.13124 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 104 | N | N | N | Estrone
 | AR: androgen receptor | 0.47059 | Nandrolone phenpropionate
 | 0.11924 | ESR1: estrogen receptor 1 |
| 105 | N | N | N | Diethylstilbestrol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.20930 | Mifepristone
 | 0.13692 | ESRRA: estrogen-related receptor alpha |
| 106 | N | N | N | Phenobarbital
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.28205 | Rosiglitazone maleate
 | 0.12510 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 108 | N | N | N | Ethinyl estradiol
 | AR: androgen receptor | 0.45946 | Mifepristone
 | 0.11924 | ESR1: estrogen receptor 1 |
| 109 | N | N | N | Diethylstilbestrol
 | AR: androgen receptor | 0.36111 | Bicalutamide
 | 0.12419 | ESRRA: estrogen-related receptor alpha |
| 110 | N | N | N | Diethylstilbestrol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.20930 | Mifepristone
 | 0.16148 | ESRRG: estrogen-related receptor gamma |
| 111 | N | N | N | Telmisartan
 | RORA: RAR-related orphan receptor A | 0.37288 | Imatinib mesilate
 | 0.17144 | PPARG: peroxisome proliferator-activated receptor gamma |
| 113 | Y | N | N | Bicalutamide
 | ESR1: estrogen receptor 1 | 0.36111 | Diethylstilbestrol
 | 0.11924 | AR: androgen receptor |
| 116 | N | N | N | Estrone sodium sulfate
 | AR: androgen receptor | 0.41026 | Nandrolone phenpropionate
 | 0.11924 | ESR1: estrogen receptor 1 |
| 118 | N | N | N | Imatinib mesilate
 | ESR1: estrogen receptor 1 | 0.45283 | Raloxifene hydrochloride
 | 0.085339 | RORA: RAR-related orphan receptor A |
| 119 | N | N | N | Phenobarbital
 | AR: androgen receptor | 0.34483 | Nilutamide
 | 0.087787 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 120 | N | N | N | Phenobarbital
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.26923 | Clofibrate
 | 0.12527 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 123 | N | N | N | Clomiphene citrate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.38889 | Rosiglitazone maleate
 | 0.10925 | ESR1: estrogen receptor 1 |
| 124 | Y | N | N | Mifepristone
 | ESR2: estrogen receptor 2 (ER beta) | 0.40541 | Estradiol
 | 0.14446 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 125 | N | N | N | Diethylstilbestrol
 | RARG: retinoic acid receptor, gamma | 0.40625 | Tazarotene
 | 0.23110 | ESRRG: estrogen-related receptor gamma |
| 126 | N | N | N | Nandrolone phenpropionate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.47619 | Mifepristone
 | 0.20529 | AR: androgen receptor |
| 128 | N | N | N | Tretinoin
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.17391 | Mifepristone
 | 0.095503 | RARG: retinoic acid receptor, gamma |
| 129 | N | N | N | Palmitic acid
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.15000 | Chenodiol
 | 0.13052 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 130 | N | N | N | Etretinate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.35484 | Clofibrate
 | 0.21233 | RARB: retinoic acid receptor, beta |
| 131 | N | N | N | Fenofibrate
 | ESR1: estrogen receptor 1 | 0.45161 | Diethylstilbestrol
 | 0.092842 | PPARA: peroxisome proliferator-activated receptor alpha |
| 134 | N | N | N | Amcinonide
 | AR: androgen receptor | 0.46342 | Fluoxymesterone
 | 0.23366 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 137 | N | N | N | Rosiglitazone maleate
 | ESR1: estrogen receptor 1 | 0.38889 | Clomiphene citrate
 | 0.10925 | PPARG: peroxisome proliferator-activated receptor gamma |
| 141 | N | N | N | Tazarotene
 | ESRRA: estrogen-related receptor alpha | 0.40625 | Diethylstilbestrol
 | 0.23672 | RXRA: retinoid X receptor, alpha |
| 144 | N | N | N | Chenodiol
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.15000 | Palmitic acid
 | 0.13052 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 145 | N | N | N | Palmitic acid
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.060606 | Phenobarbital
 | 0.15269 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 147 | N | N | N | Estramustine
 | PGR: progesterone receptor | 0.36170 | Mometasone furoate
 | 0.13120 | ESR2: estrogen receptor 2 (ER beta) |
| 148 | N | N | N | Diethylstilbestrol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.36000 | Butamben
 | 0.12402 | ESRRA: estrogen-related receptor alpha |
| 150 | Y | N | N | Mifepristone
 | ESRRA: estrogen-related receptor alpha | 0.20930 | Diethylstilbestrol
 | 0.15441 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 151 | N | N | N | Diethylstilbestrol
 | RARA: retinoic acid receptor, alpha | 0.40625 | Tazarotene
 | 0.21526 | ESRRG: estrogen-related receptor gamma |
| 153 | N | N | N | Imatinib mesilate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.28846 | Fenofibrate
 | 0.16545 | RORA: RAR-related orphan receptor A |
| 154 | N | N | N | Phenobarbital
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.060606 | Palmitic acid
 | 0.15269 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 157 | N | N | N | Tretinoin
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.18421 | Pregnenolone
 | 0.17437 | RARB: retinoic acid receptor, beta |
| 161 | N | N | N | Diethylstilbestrol
 | RORA: RAR-related orphan receptor A | 0.25265 | Imatinib mesilate
 | 0.094996 | ESRRA: estrogen-related receptor alpha |
| 163 | N | N | N | Diethylstilbestrol
 | RARB: retinoic acid receptor, beta | 0.40625 | Tazarotene
 | 0.20606 | ESRRG: estrogen-related receptor gamma |
| 164 | N | N | N | Tazarotene
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.26087 | Rosiglitazone maleate
 | 0.20203 | RARB: retinoic acid receptor, beta |
| 166 | Y | N | N | Estradiol
 | AR: androgen receptor | 0.47059 | Nandrolone phenpropionate
 | 0.11996 | ESR2: estrogen receptor 2 (ER beta) |
| 168 | N | N | N | Tazarotene
 | ESRRB: estrogen-related receptor beta | 0.40625 | Diethylstilbestrol
 | 0.23259 | RXRA: retinoid X receptor, alpha |
| 169 | N | N | N | Chenodiol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.11667 | Telmisartan
 | 0.17153 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 171 | N | N | N | Diethylstilbestrol
 | RORC: RAR-related orphan receptor C | 0.076923 | Tretinoin
 | 0.093967 | ESRRG: estrogen-related receptor gamma |
| 173 | N | N | N | Diethylstilbestrol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.076923 | Tretinoin
 | 0.051885 | ESRRG: estrogen-related receptor gamma |
| 174 | N | N | N | Mifepristone
 | ESRRG: estrogen-related receptor gamma | 0.20930 | Diethylstilbestrol
 | 0.16148 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 180 | N | N | N | Phenobarbital
 | ESR1: estrogen receptor 1 | 0.23333 | Estrone
 | 0.12743 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 182 | N | N | N | Budesonide
 | AR: androgen receptor | 0.48649 | Fluoxymesterone
 | 0.23366 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 184 | N | N | N | Butamben
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.23684 | Rosiglitazone maleate
 | 0.16215 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 185 | N | N | N | Oxandrolone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.45454 | Hydrocortisone
 | 0.23366 | AR: androgen receptor |
| 187 | N | N | N | Phenobarbital
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.046512 | Chenodiol
 | 0.19003 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 188 | N | N | N | Fenofibrate
 | AR: androgen receptor | 0.38461 | Bicalutamide
 | 0.061430 | PPARA: peroxisome proliferator-activated receptor alpha |
| 189 | N | N | N | Bicalutamide
 | ESR2: estrogen receptor 2 (ER beta) | 0.36111 | Diethylstilbestrol
 | 0.11996 | AR: androgen receptor |
| 190 | N | N | N | Palmitic acid
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.14286 | Butamben
 | 0.11513 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 191 | N | N | N | Oxandrolone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.36842 | Paricalcitol
 | 0.067869 | AR: androgen receptor |
| 193 | N | N | N | Rosiglitazone maleate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.28205 | Phenobarbital
 | 0.12510 | PPARG: peroxisome proliferator-activated receptor gamma |
| 194 | N | N | N | Dienestrol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.45161 | Fenofibrate
 | 0.092842 | ESR1: estrogen receptor 1 |
| 196 | N | N | N | Estramustine
 | AR: androgen receptor | 0.43902 | Nandrolone phenpropionate
 | 0.11996 | ESR2: estrogen receptor 2 (ER beta) |
| 197 | N | N | N | Butamben
 | ESR1: estrogen receptor 1 | 0.36000 | Diethylstilbestrol
 | 0.095273 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 198 | N | N | N | Fenofibrate
 | RORA: RAR-related orphan receptor A | 0.28846 | Imatinib mesilate
 | 0.16545 | PPARA: peroxisome proliferator-activated receptor alpha |
| 200 | N | N | N | Cholesterol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.45946 | Hydrocortisone
 | 0.061022 | RORA: RAR-related orphan receptor A |
| 201 | N | N | N | Raloxifene hydrochloride
 | ESRRB: estrogen-related receptor beta | 0.34146 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
| 202 | N | N | N | Chenodiol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.42500 | Spironolactone
 | 0.085591 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 203 | N | N | N | Estradiol
 | ESRRB: estrogen-related receptor beta | 0.25000 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
| 204 | N | N | N | Fulvestrant
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.28261 | Palmitic acid
 | 0.14814 | ESR2: estrogen receptor 2 (ER beta) |
| 208 | N | N | N | Mometasone furoate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.41304 | Eplerenone
 | 0.23099 | PGR: progesterone receptor |
| 209 | N | N | N | Palmitic acid
 | RORA: RAR-related orphan receptor A | 0.095238 | Cholesterol
 | 0.097709 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 210 | N | N | N | Bicalutamide
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.38461 | Fenofibrate
 | 0.061430 | AR: androgen receptor |
| 211 | N | N | N | Clofibrate
 | AR: androgen receptor | 0.25000 | Flutamide
 | 0.061430 | PPARA: peroxisome proliferator-activated receptor alpha |
| 212 | N | N | N | Mifepristone
 | ESRRB: estrogen-related receptor beta | 0.20930 | Diethylstilbestrol
 | 0.14423 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 213 | N | N | N | Tazarotene
 | AR: androgen receptor | 0.31707 | Bicalutamide
 | 0.10468 | RXRA: retinoid X receptor, alpha |
| 215 | N | N | N | Palmitic acid
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.062500 | Clofibrate
 | 0.13213 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 216 | N | N | N | Clofibrate
 | RARA: retinoic acid receptor, alpha | 0.41379 | Tazarotene
 | 0.20153 | PPARA: peroxisome proliferator-activated receptor alpha |
| 219 | N | N | N | Nilutamide
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.34483 | Phenobarbital
 | 0.087787 | AR: androgen receptor |
| 220 | N | N | N | Diethylstilbestrol
 | RORB: RAR-related orphan receptor B | 0.40625 | Tazarotene
 | 0.10275 | ESRRA: estrogen-related receptor alpha |
| 221 | N | N | N | Tazarotene
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.34483 | Butamben
 | 0.17437 | RARB: retinoic acid receptor, beta |
| 222 | N | N | N | Chenodiol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.046512 | Phenobarbital
 | 0.19003 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 224 | N | N | N | Telmisartan
 | ESR1: estrogen receptor 1 | 0.29608 | Clomiphene citrate
 | 0.10925 | PPARG: peroxisome proliferator-activated receptor gamma |
| 226 | Y | N | N | Estradiol
 | PGR: progesterone receptor | 0.40541 | Mifepristone
 | 0.13120 | ESR2: estrogen receptor 2 (ER beta) |
| 227 | N | N | N | Chenodiol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.42105 | Hydrocortisone
 | 0.092251 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 229 | N | N | N | Dihydrotachysterol
 | RARA: retinoic acid receptor, alpha | 0.34210 | Tretinoin
 | 0.17498 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 231 | N | N | N | Tazarotene
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.10417 | Chenodiol
 | 0.19755 | RARB: retinoic acid receptor, beta |
| 234 | N | N | N | Clofibrate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.26923 | Phenobarbital
 | 0.12527 | PPARA: peroxisome proliferator-activated receptor alpha |
| 235 | N | N | N | Telmisartan
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.20455 | Butamben
 | 0.16215 | PPARG: peroxisome proliferator-activated receptor gamma |
| 236 | N | N | N | Imatinib mesilate
 | AR: androgen receptor | 0.32722 | Bicalutamide
 | 0.055679 | RORA: RAR-related orphan receptor A |
| 239 | N | N | N | Spironolactone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.42500 | Chenodiol
 | 0.085591 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 240 | N | N | N | Imatinib mesilate
 | ESR2: estrogen receptor 2 (ER beta) | 0.45283 | Raloxifene hydrochloride
 | 0.088647 | RORA: RAR-related orphan receptor A |
| 241 | N | N | N | Chenodiol
 | PGR: progesterone receptor | 0.45714 | Progesterone
 | 0.077571 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 243 | N | N | N | Calcitriol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.48718 | Chenodiol
 | 0.20226 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 244 | N | N | N | Dihydrotachysterol
 | PGR: progesterone receptor | 0.35714 | Medroxyprogesterone acetate
 | 0.060029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 245 | N | N | N | Rosiglitazone maleate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.15909 | Palmitic acid
 | 0.13124 | PPARG: peroxisome proliferator-activated receptor gamma |
| 246 | N | N | N | Calcitriol
 | ESR1: estrogen receptor 1 | 0.35897 | Progesterone
 | 0.11238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 247 | N | N | N | Ergocalciferol
 | RARA: retinoic acid receptor, alpha | 0.34210 | Tretinoin
 | 0.17498 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 248 | N | N | N | Diethylstilbestrol
 | PGR: progesterone receptor | 0.20930 | Mifepristone
 | 0.14238 | ESRRA: estrogen-related receptor alpha |
| 250 | N | N | N | Clofibrate
 | ESR1: estrogen receptor 1 | 0.33333 | Diethylstilbestrol
 | 0.092842 | PPARA: peroxisome proliferator-activated receptor alpha |
| 251 | N | N | N | Telmisartan
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.14000 | Palmitic acid
 | 0.13124 | PPARG: peroxisome proliferator-activated receptor gamma |
| 252 | N | N | N | Eplerenone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.28889 | Cholecalciferol
 | 0.076190 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 253 | N | N | N | Rifampin
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.26667 | Amcinonide
 | 0.071609 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 254 | N | N | N | Raloxifene hydrochloride
 | RORA: RAR-related orphan receptor A | 0.45283 | Imatinib mesilate
 | 0.088647 | ESR2: estrogen receptor 2 (ER beta) |
| 255 | N | N | N | Estramustine
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.38636 | Loteprednol etabonate
 | 0.14446 | ESR2: estrogen receptor 2 (ER beta) |
| 256 | N | N | N | Mifepristone
 | RXRA: retinoid X receptor, alpha | 0.23913 | Tazarotene
 | 0.11451 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 257 | N | N | N | Norgestrel
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.48649 | Mifepristone
 | 0.23099 | PGR: progesterone receptor |
| 258 | N | N | N | Levonorgestrel
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.48649 | Mifepristone
 | 0.23099 | PGR: progesterone receptor |
| 259 | N | N | N | Rosiglitazone maleate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.23684 | Butamben
 | 0.16215 | PPARG: peroxisome proliferator-activated receptor gamma |
| 260 | N | N | N | Desogestrel
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.34210 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 261 | N | N | N | Palmitic acid
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.11111 | Tretinoin
 | 0.067201 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 262 | N | N | N | Etretinate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.22222 | Dihydrotachysterol
 | 0.18311 | RARG: retinoic acid receptor, gamma |
| 263 | N | N | N | Tazarotene
 | PGR: progesterone receptor | 0.23913 | Mifepristone
 | 0.10416 | RXRA: retinoid X receptor, alpha |
| 264 | N | N | N | Tretinoin
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.17391 | Mifepristone
 | 0.11451 | RXRA: retinoid X receptor, alpha |
| 265 | N | N | N | Phenobarbital
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.19512 | Mifepristone
 | 0.094019 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 266 | N | N | N | Flutamide
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.29412 | Fenofibrate
 | 0.061430 | AR: androgen receptor |
| 267 | N | N | N | Fenofibrate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.30000 | Butamben
 | 0.14611 | PPARA: peroxisome proliferator-activated receptor alpha |
| 268 | N | N | N | Rosiglitazone maleate
 | AR: androgen receptor | 0.24000 | Bicalutamide
 | 0.063846 | PPARG: peroxisome proliferator-activated receptor gamma |
| 269 | N | N | N | Tazarotene
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.16667 | Phenobarbital
 | 0.18237 | RARG: retinoic acid receptor, gamma |
| 270 | N | N | N | Chenodiol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.081633 | Fenofibrate
 | 0.15232 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 272 | N | N | N | Phenobarbital
 | RORA: RAR-related orphan receptor A | 0.11321 | Imatinib mesilate
 | 0.10498 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 274 | N | N | N | Mifepristone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.19512 | Phenobarbital
 | 0.10736 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 275 | N | N | N | Butamben
 | ESR2: estrogen receptor 2 (ER beta) | 0.36000 | Diethylstilbestrol
 | 0.088787 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 276 | N | N | N | Telmisartan
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.11667 | Chenodiol
 | 0.17153 | PPARG: peroxisome proliferator-activated receptor gamma |
| 277 | N | N | N | Phenobarbital
 | ESRRA: estrogen-related receptor alpha | 0.23333 | Diethylstilbestrol
 | 0.16999 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 279 | N | N | N | Paricalcitol
 | RARA: retinoic acid receptor, alpha | 0.33333 | Tretinoin
 | 0.17498 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 280 | N | N | N | Mifepristone
 | RXRB: retinoid X receptor, beta | 0.23913 | Tazarotene
 | 0.10128 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 283 | N | N | N | Chenodiol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.21951 | Tretinoin
 | 0.036079 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 284 | N | N | N | Amcinonide
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.30612 | Cholecalciferol
 | 0.064100 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 285 | N | N | N | Bicalutamide
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.24000 | Rosiglitazone maleate
 | 0.063846 | AR: androgen receptor |
| 286 | N | N | N | Spironolactone
 | RORA: RAR-related orphan receptor A | 0.42500 | Cholesterol
 | 0.061072 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 287 | N | N | N | Rosiglitazone maleate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.10909 | Cholecalciferol
 | 0.18238 | PPARG: peroxisome proliferator-activated receptor gamma |
| 288 | N | N | N | Palmitic acid
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.095238 | Cholecalciferol
 | 0.11942 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 290 | N | N | N | Cholecalciferol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.47368 | Chenodiol
 | 0.20226 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 292 | N | N | N | Budesonide
 | ESR1: estrogen receptor 1 | 0.48649 | Fluoxymesterone
 | 0.13105 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 293 | N | N | N | Phenobarbital
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.19512 | Mifepristone
 | 0.10736 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 295 | N | N | N | Eplerenone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.39474 | Pregnenolone
 | 0.075614 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 296 | N | N | N | Palmitic acid
 | ESR1: estrogen receptor 1 | 0.28261 | Fulvestrant
 | 0.14077 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 297 | N | N | N | Tazarotene
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.23913 | Mifepristone
 | 0.095503 | RARG: retinoic acid receptor, gamma |
| 298 | N | N | N | Cholesterol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.42500 | Spironolactone
 | 0.061072 | RORA: RAR-related orphan receptor A |
| 300 | N | N | N | Phenobarbital
 | ESRRB: estrogen-related receptor beta | 0.23333 | Diethylstilbestrol
 | 0.15794 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 301 | N | N | N | Paricalcitol
 | ESR1: estrogen receptor 1 | 0.35897 | Progesterone
 | 0.11238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 302 | N | N | N | Diethylstilbestrol
 | RXRG: retinoid X receptor, gamma | 0.40625 | Tazarotene
 | 0.040802 | ESRRG: estrogen-related receptor gamma |
| 304 | N | N | N | Butamben
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.14286 | Palmitic acid
 | 0.11513 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 305 | N | N | N | Amcinonide
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.37209 | Pregnenolone
 | 0.071609 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 306 | N | N | N | Mifepristone
 | RXRG: retinoid X receptor, gamma | 0.23913 | Tazarotene
 | 0.042474 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 307 | N | N | N | Paricalcitol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.45000 | Chenodiol
 | 0.20226 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 308 | N | N | N | Mifepristone
 | RARG: retinoic acid receptor, gamma | 0.23913 | Tazarotene
 | 0.099896 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 309 | N | N | N | Rosiglitazone maleate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.10909 | Chenodiol
 | 0.17153 | PPARG: peroxisome proliferator-activated receptor gamma |
| 310 | N | N | N | Clofibrate
 | RARB: retinoic acid receptor, beta | 0.41379 | Tazarotene
 | 0.21233 | PPARA: peroxisome proliferator-activated receptor alpha |
| 311 | N | N | N | Nilutamide
 | ESR1: estrogen receptor 1 | 0.31250 | Estrone
 | 0.11924 | AR: androgen receptor |
| 312 | N | N | N | Etretinate
 | ESR1: estrogen receptor 1 | 0.17949 | Diethylstilbestrol
 | 0.18294 | RXRA: retinoid X receptor, alpha |
| 313 | Y | N | N | Cholecalciferol
 | ESR1: estrogen receptor 1 | 0.37838 | Progesterone
 | 0.11238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 314 | N | N | N | Fulvestrant
 | ESRRB: estrogen-related receptor beta | 0.17308 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
| 315 | N | N | N | Tretinoin
 | ESR2: estrogen receptor 2 (ER beta) | 0.10526 | Estradiol
 | 0.16853 | RXRA: retinoid X receptor, alpha |
| 316 | N | N | N | Fenofibrate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.10417 | Cholecalciferol
 | 0.16326 | PPARA: peroxisome proliferator-activated receptor alpha |
| 317 | N | N | N | Dihydrotachysterol
 | AR: androgen receptor | 0.35897 | Fluoxymesterone
 | 0.067869 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 318 | N | N | N | Phenobarbital
 | ESRRG: estrogen-related receptor gamma | 0.23333 | Diethylstilbestrol
 | 0.16198 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 319 | N | N | N | Fenofibrate
 | RARA: retinoic acid receptor, alpha | 0.42857 | Tazarotene
 | 0.20153 | PPARA: peroxisome proliferator-activated receptor alpha |
| 321 | N | N | N | Fenofibrate
 | ESR2: estrogen receptor 2 (ER beta) | 0.45161 | Diethylstilbestrol
 | 0.096117 | PPARA: peroxisome proliferator-activated receptor alpha |
| 323 | N | N | N | Fenofibrate
 | ESRRG: estrogen-related receptor gamma | 0.45161 | Diethylstilbestrol
 | 0.14241 | PPARA: peroxisome proliferator-activated receptor alpha |
| 324 | N | N | N | Clofibrate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.23077 | Mifepristone
 | 0.077024 | PPARA: peroxisome proliferator-activated receptor alpha |
| 325 | N | N | N | Tretinoin
 | PGR: progesterone receptor | 0.19048 | Medroxyprogesterone acetate
 | 0.10416 | RXRA: retinoid X receptor, alpha |
| 326 | N | N | N | Raloxifene hydrochloride
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.27624 | Telmisartan
 | 0.10925 | ESR1: estrogen receptor 1 |
| 327 | N | N | N | Cholesterol
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.095238 | Palmitic acid
 | 0.097709 | RORA: RAR-related orphan receptor A |
| 328 | N | N | N | Chenodiol
 | RORC: RAR-related orphan receptor C | 0.21951 | Tretinoin
 | 0.10827 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 329 | N | N | N | Budesonide
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.31111 | Cholecalciferol
 | 0.064100 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 330 | N | N | N | Mifepristone
 | RARA: retinoic acid receptor, alpha | 0.23913 | Tazarotene
 | 0.095668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 331 | N | N | N | Medroxyprogesterone acetate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.35714 | Ergocalciferol
 | 0.060029 | PGR: progesterone receptor |
| 332 | N | N | N | Etretinate
 | ESR2: estrogen receptor 2 (ER beta) | 0.17949 | Diethylstilbestrol
 | 0.16853 | RXRA: retinoid X receptor, alpha |
| 333 | N | N | N | Imatinib mesilate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.16092 | Rifampin
 | 0.13841 | RORA: RAR-related orphan receptor A |
| 335 | N | N | N | Rifampin
 | RORA: RAR-related orphan receptor A | 0.20833 | Cholesterol
 | 0.13841 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 336 | N | N | N | Fulvestrant
 | AR: androgen receptor | 0.29091 | Nandrolone phenpropionate
 | 0.11996 | ESR2: estrogen receptor 2 (ER beta) |
| 337 | N | N | N | Dienestrol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.29268 | Rosiglitazone maleate
 | 0.10925 | ESR1: estrogen receptor 1 |
| 338 | N | N | N | Rifampin
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10843 | Rosiglitazone maleate
 | 0.16215 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 339 | N | N | N | Phenobarbital
 | PGR: progesterone receptor | 0.19512 | Mifepristone
 | 0.092601 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 340 | N | N | N | Estramustine
 | ESRRB: estrogen-related receptor beta | 0.19512 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
| 341 | N | N | N | Dienestrol
 | AR: androgen receptor | 0.32432 | Bicalutamide
 | 0.11924 | ESR1: estrogen receptor 1 |
| 342 | N | N | N | Clofibrate
 | RARG: retinoic acid receptor, gamma | 0.41379 | Tazarotene
 | 0.20327 | PPARA: peroxisome proliferator-activated receptor alpha |
| 343 | N | N | N | Fenofibrate
 | ESRRB: estrogen-related receptor beta | 0.45161 | Diethylstilbestrol
 | 0.12375 | PPARA: peroxisome proliferator-activated receptor alpha |
| 344 | N | N | N | Mifepristone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.35556 | Dihydrotachysterol
 | 0.076190 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 345 | N | N | N | Rifampin
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.19178 | Chenodiol
 | 0.18905 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 346 | N | N | N | Eplerenone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.34884 | Chenodiol
 | 0.085591 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 347 | N | N | N | Rifampin
 | RARA: retinoic acid receptor, alpha | 0.19718 | Etretinate
 | 0.16725 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 348 | N | N | N | Mifepristone
 | RORB: RAR-related orphan receptor B | 0.23913 | Tazarotene
 | 0.071358 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 349 | N | N | N | Clomiphene citrate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.28846 | Fenofibrate
 | 0.092842 | ESR1: estrogen receptor 1 |
| 350 | N | N | N | Tazarotene
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.23913 | Mifepristone
 | 0.11451 | RXRA: retinoid X receptor, alpha |
| 351 | N | N | N | Clofibrate
 | RXRA: retinoid X receptor, alpha | 0.41379 | Tazarotene
 | 0.17514 | PPARA: peroxisome proliferator-activated receptor alpha |
| 352 | N | N | N | Clofibrate
 | RXRG: retinoid X receptor, gamma | 0.41379 | Tazarotene
 | 0.032006 | PPARA: peroxisome proliferator-activated receptor alpha |
| 353 | N | N | N | Ethinyl estradiol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.45946 | Mifepristone
 | 0.13105 | ESR1: estrogen receptor 1 |
| 354 | N | N | N | Palmitic acid
 | ESRRB: estrogen-related receptor beta | 0.085714 | Diethylstilbestrol
 | 0.19080 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 355 | N | N | N | Rosiglitazone maleate
 | RORA: RAR-related orphan receptor A | 0.17188 | Imatinib mesilate
 | 0.17144 | PPARG: peroxisome proliferator-activated receptor gamma |
| 356 | N | N | N | Telmisartan
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.080645 | Cholecalciferol
 | 0.18238 | PPARG: peroxisome proliferator-activated receptor gamma |
| 357 | N | N | N | Dydrogesterone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.34210 | Cholecalciferol
 | 0.060029 | PGR: progesterone receptor |
| 358 | N | N | N | Palmitic acid
 | ESRRA: estrogen-related receptor alpha | 0.085714 | Diethylstilbestrol
 | 0.18497 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 360 | N | N | N | Palmitic acid
 | ESRRG: estrogen-related receptor gamma | 0.085714 | Diethylstilbestrol
 | 0.19965 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 361 | N | N | N | Nandrolone phenpropionate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.39474 | Pregnenolone
 | 0.064846 | AR: androgen receptor |
| 362 | N | N | N | Palmitic acid
 | RORC: RAR-related orphan receptor C | 0.11111 | Tretinoin
 | 0.10208 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 363 | N | N | N | Ethynodiol diacetate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.42500 | Spironolactone
 | 0.23099 | PGR: progesterone receptor |
| 364 | N | N | N | Dihydrotachysterol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.35556 | Mifepristone
 | 0.064100 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 365 | N | N | N | Chenodiol
 | ESR2: estrogen receptor 2 (ER beta) | 0.33333 | Estradiol
 | 0.12692 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 366 | N | N | N | Ergocalciferol
 | PGR: progesterone receptor | 0.36842 | Progesterone
 | 0.060029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 367 | N | N | N | Telmisartan
 | AR: androgen receptor | 0.23636 | Bicalutamide
 | 0.063846 | PPARG: peroxisome proliferator-activated receptor gamma |
| 368 | N | N | N | Mometasone furoate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.22449 | Fenofibrate
 | 0.059277 | PGR: progesterone receptor |
| 369 | N | N | N | Rosiglitazone maleate
 | RARA: retinoic acid receptor, alpha | 0.26087 | Tazarotene
 | 0.19466 | PPARG: peroxisome proliferator-activated receptor gamma |
| 370 | N | N | N | Dihydrotachysterol
 | ESR1: estrogen receptor 1 | 0.35897 | Fluoxymesterone
 | 0.11238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 371 | N | N | N | Etretinate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.16071 | Telmisartan
 | 0.20203 | RARB: retinoic acid receptor, beta |
| 372 | N | N | N | Mifepristone
 | RARB: retinoic acid receptor, beta | 0.23913 | Tazarotene
 | 0.096751 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 373 | N | N | N | Mifepristone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.23077 | Clofibrate
 | 0.077024 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 374 | N | N | N | Etretinate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.21212 | Butamben
 | 0.17437 | RARB: retinoic acid receptor, beta |
| 375 | N | N | N | Chenodiol
 | RARA: retinoic acid receptor, alpha | 0.21951 | Tretinoin
 | 0.18904 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 376 | N | N | N | Estradiol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.29730 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 377 | N | N | N | Etretinate
 | ESRRA: estrogen-related receptor alpha | 0.17949 | Diethylstilbestrol
 | 0.23672 | RXRA: retinoid X receptor, alpha |
| 378 | N | N | N | Ethynodiol diacetate
 | RXRA: retinoid X receptor, alpha | 0.20455 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
| 379 | N | N | N | Mifepristone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.27660 | Chenodiol
 | 0.092251 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 380 | N | N | N | Mifepristone
 | RORC: RAR-related orphan receptor C | 0.17391 | Tretinoin
 | 0.064847 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 381 | N | N | N | Calcitriol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.33333 | Hydrocortisone
 | 0.064100 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 382 | N | N | N | Clomiphene citrate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.20000 | Palmitic acid
 | 0.14077 | ESR1: estrogen receptor 1 |
| 383 | N | N | N | Palmitic acid
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.088889 | Budesonide
 | 0.10292 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 384 | N | N | N | Loteprednol etabonate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.37500 | Pregnenolone
 | 0.071609 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 385 | N | N | N | Butamben
 | ESRRA: estrogen-related receptor alpha | 0.36000 | Diethylstilbestrol
 | 0.12402 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 386 | N | N | N | Clomiphene citrate
 | PGR: progesterone receptor | 0.13846 | Mifepristone
 | 0.12952 | ESR1: estrogen receptor 1 |
| 387 | N | N | N | Loteprednol etabonate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.20000 | Clofibrate
 | 0.077024 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 388 | N | N | N | Diethylstilbestrol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.086957 | Calcitriol
 | 0.14277 | ESRRG: estrogen-related receptor gamma |
| 389 | N | N | N | Telmisartan
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.14286 | Phenobarbital
 | 0.12510 | PPARG: peroxisome proliferator-activated receptor gamma |
| 390 | N | N | N | Oxandrolone
 | RORA: RAR-related orphan receptor A | 0.47059 | Cholesterol
 | 0.055679 | AR: androgen receptor |
| 391 | N | N | N | Testosterone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.36111 | Cholecalciferol
 | 0.067869 | AR: androgen receptor |
| 392 | N | N | N | Clofibrate
 | RXRB: retinoid X receptor, beta | 0.41379 | Tazarotene
 | 0.14777 | PPARA: peroxisome proliferator-activated receptor alpha |
| 393 | N | N | N | Ethynodiol diacetate
 | RARA: retinoic acid receptor, alpha | 0.20455 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
| 394 | N | N | N | Palmitic acid
 | ESR2: estrogen receptor 2 (ER beta) | 0.28261 | Fulvestrant
 | 0.14814 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 395 | N | N | N | Fluoxymesterone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.36842 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 396 | N | N | N | Nilutamide
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.22222 | Rosiglitazone maleate
 | 0.063846 | AR: androgen receptor |
| 397 | N | N | N | Fenofibrate
 | ESRRA: estrogen-related receptor alpha | 0.45161 | Diethylstilbestrol
 | 0.11006 | PPARA: peroxisome proliferator-activated receptor alpha |
| 398 | N | N | N | Clofibrate
 | RORA: RAR-related orphan receptor A | 0.18367 | Imatinib mesilate
 | 0.16545 | PPARA: peroxisome proliferator-activated receptor alpha |
| 399 | N | N | N | Fulvestrant
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.26786 | Calcitriol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 400 | N | N | N | Clofibrate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.062500 | Palmitic acid
 | 0.13213 | PPARA: peroxisome proliferator-activated receptor alpha |
| 401 | N | N | N | Mifepristone
 | RORA: RAR-related orphan receptor A | 0.36364 | Cholesterol
 | 0.061072 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 402 | N | N | N | Eplerenone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.12195 | Clofibrate
 | 0.069941 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 403 | N | N | N | Telmisartan
 | RARA: retinoic acid receptor, alpha | 0.23077 | Tazarotene
 | 0.19466 | PPARG: peroxisome proliferator-activated receptor gamma |
| 404 | N | N | N | Eplerenone
 | RORA: RAR-related orphan receptor A | 0.34884 | Cholesterol
 | 0.061072 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 405 | N | N | N | Estramustine
 | RXRA: retinoid X receptor, alpha | 0.28571 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
| 406 | N | N | N | Calcitriol
 | AR: androgen receptor | 0.35000 | Fluoxymesterone
 | 0.067869 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 407 | N | N | N | Cholecalciferol
 | AR: androgen receptor | 0.36842 | Fluoxymesterone
 | 0.067869 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 408 | N | N | N | Dienestrol
 | PGR: progesterone receptor | 0.20930 | Mifepristone
 | 0.12952 | ESR1: estrogen receptor 1 |
| 409 | N | N | N | Butamben
 | ESRRB: estrogen-related receptor beta | 0.36000 | Diethylstilbestrol
 | 0.11252 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 410 | N | N | N | Ethynodiol diacetate
 | RXRB: retinoid X receptor, beta | 0.20455 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
| 411 | N | N | N | Ethinyl estradiol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.26829 | Calcitriol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 412 | N | N | N | Hydrocortisone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.42105 | Chenodiol
 | 0.092251 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 413 | N | N | N | Bicalutamide
 | RORA: RAR-related orphan receptor A | 0.32722 | Imatinib mesilate
 | 0.055679 | AR: androgen receptor |
| 414 | N | N | N | Norethindrone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.31579 | Cholecalciferol
 | 0.060029 | PGR: progesterone receptor |
| 415 | N | N | N | Cholesterol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10417 | Fenofibrate
 | 0.16545 | RORA: RAR-related orphan receptor A |
| 416 | N | N | N | Ergocalciferol
 | ESR1: estrogen receptor 1 | 0.36842 | Progesterone
 | 0.11238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 417 | N | N | N | Fenofibrate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.21277 | Mifepristone
 | 0.077024 | PPARA: peroxisome proliferator-activated receptor alpha |
| 418 | N | N | N | Hydrocortisone
 | RORA: RAR-related orphan receptor A | 0.45946 | Cholesterol
 | 0.061022 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 419 | N | N | N | Rifampin
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.15069 | Fenofibrate
 | 0.14611 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 420 | N | N | N | Budesonide
 | RORA: RAR-related orphan receptor A | 0.37209 | Cholesterol
 | 0.061022 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 421 | N | N | N | Dihydrotachysterol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.35556 | Mifepristone
 | 0.076190 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 423 | N | N | N | Flutamide
 | ESR1: estrogen receptor 1 | 0.23077 | Estramustine
 | 0.11924 | AR: androgen receptor |
| 424 | N | N | N | Medroxyprogesterone acetate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.17778 | Fenofibrate
 | 0.059277 | PGR: progesterone receptor |
| 425 | N | N | N | Estramustine
 | RXRB: retinoid X receptor, beta | 0.28571 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
| 426 | N | N | N | Amcinonide
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.15556 | Clofibrate
 | 0.077024 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 427 | Y | N | N | Fulvestrant
 | PGR: progesterone receptor | 0.23729 | Mifepristone
 | 0.13120 | ESR2: estrogen receptor 2 (ER beta) |
| 428 | N | N | N | Spironolactone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.28889 | Dihydrotachysterol
 | 0.076190 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 429 | N | N | N | Medroxyprogesterone acetate
 | RARA: retinoic acid receptor, alpha | 0.19048 | Tretinoin
 | 0.084891 | PGR: progesterone receptor |
| 430 | N | N | N | Butamben
 | ESRRG: estrogen-related receptor gamma | 0.36000 | Diethylstilbestrol
 | 0.11500 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 431 | N | N | N | Cholecalciferol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.33333 | Mifepristone
 | 0.064100 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 432 | N | N | N | Spironolactone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.095238 | Phenobarbital
 | 0.094019 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 433 | N | N | N | Medroxyprogesterone acetate
 | RORA: RAR-related orphan receptor A | 0.47368 | Cholesterol
 | 0.057820 | PGR: progesterone receptor |
| 434 | N | N | N | Imatinib mesilate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.11321 | Phenobarbital
 | 0.10498 | RORA: RAR-related orphan receptor A |
| 435 | N | N | N | Phenobarbital
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.054054 | Tretinoin
 | 0.028787 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 436 | N | N | N | Clofibrate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.095238 | Calcitriol
 | 0.16326 | PPARA: peroxisome proliferator-activated receptor alpha |
| 437 | N | N | N | Dihydrotachysterol
 | RORA: RAR-related orphan receptor A | 0.46250 | Cholesterol
 | 0.16329 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 438 | N | N | N | Estrone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.26316 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 439 | N | N | N | Etretinate
 | ESRRB: estrogen-related receptor beta | 0.17949 | Diethylstilbestrol
 | 0.23259 | RXRA: retinoid X receptor, alpha |
| 440 | N | N | N | Imatinib mesilate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.034483 | Palmitic acid
 | 0.097709 | RORA: RAR-related orphan receptor A |
| 441 | N | N | N | Etretinate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.080000 | Chenodiol
 | 0.19755 | RARB: retinoic acid receptor, beta |
| 442 | N | N | N | Cholesterol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.080645 | Telmisartan
 | 0.17144 | RORA: RAR-related orphan receptor A |
| 443 | N | N | N | Cholecalciferol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10909 | Rosiglitazone maleate
 | 0.18238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 445 | N | N | N | Rosiglitazone maleate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.18182 | Mifepristone
 | 0.068035 | PPARG: peroxisome proliferator-activated receptor gamma |
| 446 | N | N | N | Nilutamide
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.22581 | Clofibrate
 | 0.061430 | AR: androgen receptor |
| 447 | N | N | N | Cholecalciferol
 | PGR: progesterone receptor | 0.37838 | Progesterone
 | 0.060029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 448 | N | N | N | Ergocalciferol
 | AR: androgen receptor | 0.35897 | Fluoxymesterone
 | 0.067869 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 449 | N | N | N | Imatinib mesilate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.21311 | Mifepristone
 | 0.061022 | RORA: RAR-related orphan receptor A |
| 450 | Y | N | N | Estradiol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.40541 | Mifepristone
 | 0.14446 | ESR2: estrogen receptor 2 (ER beta) |
| 451 | N | N | N | Nandrolone phenpropionate
 | ESR2: estrogen receptor 2 (ER beta) | 0.47059 | Estradiol
 | 0.11996 | AR: androgen receptor |
| 452 | N | N | N | Pregnenolone
 | RORC: RAR-related orphan receptor C | 0.18421 | Tretinoin
 | 0.15608 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 453 | N | N | N | Clofibrate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.23077 | Mifepristone
 | 0.069941 | PPARA: peroxisome proliferator-activated receptor alpha |
| 454 | N | N | N | Nandrolone phenpropionate
 | RORA: RAR-related orphan receptor A | 0.41463 | Cholesterol
 | 0.055679 | AR: androgen receptor |
| 456 | N | N | N | Mifepristone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.17391 | Tretinoin
 | 0.020772 | PGR: progesterone receptor |
| 457 | N | N | N | Chenodiol
 | ESRRG: estrogen-related receptor gamma | 0.090909 | Diethylstilbestrol
 | 0.15388 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 458 | N | N | N | Imatinib mesilate
 | RARA: retinoic acid receptor, alpha | 0.31372 | Tazarotene
 | 0.15182 | RORA: RAR-related orphan receptor A |
| 459 | N | N | N | Butamben
 | RARA: retinoic acid receptor, alpha | 0.34483 | Tazarotene
 | 0.16725 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 460 | N | N | N | Isotretinoin
 | AR: androgen receptor | 0.17949 | Fluoxymesterone
 | 0.087217 | RARA: retinoic acid receptor, alpha |
| 462 | N | N | N | Chenodiol
 | ESRRB: estrogen-related receptor beta | 0.090909 | Diethylstilbestrol
 | 0.14022 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 463 | N | N | N | Tretinoin
 | AR: androgen receptor | 0.17949 | Fluoxymesterone
 | 0.10468 | RXRA: retinoid X receptor, alpha |
| 464 | N | N | N | Ethynodiol diacetate
 | RARG: retinoic acid receptor, gamma | 0.20455 | Tazarotene
 | 0.14846 | ESR1: estrogen receptor 1 |
| 465 | N | N | N | Imatinib mesilate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.12903 | Chenodiol
 | 0.13581 | RORA: RAR-related orphan receptor A |
| 466 | N | N | N | Tretinoin
 | ESR1: estrogen receptor 1 | 0.18421 | Progesterone
 | 0.18294 | RXRA: retinoid X receptor, alpha |
| 467 | N | N | N | Butamben
 | AR: androgen receptor | 0.25714 | Nandrolone phenpropionate
 | 0.064846 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 468 | N | N | N | Estrone sodium sulfate
 | RORA: RAR-related orphan receptor A | 0.26415 | Imatinib mesilate
 | 0.085339 | ESR1: estrogen receptor 1 |
| 470 | N | N | N | Etretinate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.10256 | Phenobarbital
 | 0.18237 | RARG: retinoic acid receptor, gamma |
| 471 | N | N | N | Nilutamide
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.20000 | Mifepristone
 | 0.20529 | AR: androgen receptor |
| 472 | N | N | N | Calcitriol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10526 | Rosiglitazone maleate
 | 0.18238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 473 | N | N | N | Spironolactone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.021739 | Palmitic acid
 | 0.082312 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 474 | N | N | N | Eplerenone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.093023 | Phenobarbital
 | 0.094019 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 475 | N | N | N | Chenodiol
 | ESRRA: estrogen-related receptor alpha | 0.090909 | Diethylstilbestrol
 | 0.13665 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 476 | N | N | N | Mifepristone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.020408 | Palmitic acid
 | 0.10292 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 477 | N | N | N | Ethynodiol diacetate
 | RARB: retinoic acid receptor, beta | 0.20455 | Tazarotene
 | 0.14884 | ESR1: estrogen receptor 1 |
| 478 | N | N | N | Palmitic acid
 | RARA: retinoic acid receptor, alpha | 0.11111 | Tretinoin
 | 0.17474 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 480 | N | N | N | Fenofibrate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.081633 | Chenodiol
 | 0.15232 | PPARA: peroxisome proliferator-activated receptor alpha |
| 481 | N | N | N | Imatinib mesilate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.21311 | Mifepristone
 | 0.061072 | RORA: RAR-related orphan receptor A |
| 482 | N | N | N | Clofibrate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.073171 | Chenodiol
 | 0.15232 | PPARA: peroxisome proliferator-activated receptor alpha |
| 483 | N | N | N | Fenofibrate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.16667 | Phenobarbital
 | 0.12527 | PPARA: peroxisome proliferator-activated receptor alpha |
| 485 | N | N | N | Spironolactone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.080000 | Fenofibrate
 | 0.069941 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 486 | N | N | N | Loteprednol etabonate
 | RARA: retinoic acid receptor, alpha | 0.18750 | Tazarotene
 | 0.095668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 487 | N | N | N | Estramustine
 | RARA: retinoic acid receptor, alpha | 0.28571 | Tazarotene
 | 0.14896 | ESR2: estrogen receptor 2 (ER beta) |
| 488 | N | N | N | Calcitriol
 | PGR: progesterone receptor | 0.35897 | Progesterone
 | 0.060029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 490 | N | N | N | Telmisartan
 | ESR2: estrogen receptor 2 (ER beta) | 0.28261 | Diethylstilbestrol
 | 0.094479 | PPARG: peroxisome proliferator-activated receptor gamma |
| 491 | N | N | N | Fenofibrate
 | RARB: retinoic acid receptor, beta | 0.42857 | Tazarotene
 | 0.21233 | PPARA: peroxisome proliferator-activated receptor alpha |
| 492 | N | N | N | Estrone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.34375 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
| 494 | N | N | N | Spironolactone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.068966 | Rosiglitazone maleate
 | 0.066795 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 495 | N | N | N | Phenobarbital
 | RORC: RAR-related orphan receptor C | 0.054054 | Tretinoin
 | 0.10540 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 496 | N | N | N | Paricalcitol
 | AR: androgen receptor | 0.36842 | Oxandrolone
 | 0.067869 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 497 | N | N | N | Mifepristone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.18182 | Rosiglitazone maleate
 | 0.069755 | PGR: progesterone receptor |
| 498 | N | N | N | Rosiglitazone maleate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.18182 | Mifepristone
 | 0.066795 | PPARG: peroxisome proliferator-activated receptor gamma |
| 499 | N | N | N | Fenofibrate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.21277 | Mifepristone
 | 0.069941 | PPARA: peroxisome proliferator-activated receptor alpha |
| 501 | N | N | N | Budesonide
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.088889 | Palmitic acid
 | 0.10292 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 502 | N | N | N | Nandrolone phenpropionate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.31818 | Cholecalciferol
 | 0.067869 | AR: androgen receptor |
| 503 | N | N | N | Butamben
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.076923 | Chenodiol
 | 0.18905 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 505 | N | N | N | Chenodiol
 | RORB: RAR-related orphan receptor B | 0.21951 | Tretinoin
 | 0.14486 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 506 | N | N | N | Fulvestrant
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.27778 | Chenodiol
 | 0.12692 | ESR2: estrogen receptor 2 (ER beta) |
| 507 | N | N | N | Fulvestrant
 | RORA: RAR-related orphan receptor A | 0.27778 | Cholesterol
 | 0.088647 | ESR2: estrogen receptor 2 (ER beta) |
| 508 | N | N | N | Flutamide
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.22222 | Butamben
 | 0.064846 | AR: androgen receptor |
| 509 | N | N | N | Eplerenone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.021277 | Palmitic acid
 | 0.082312 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 511 | N | N | N | Desogestrel
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.41026 | Mifepristone
 | 0.23099 | PGR: progesterone receptor |
| 512 | N | N | N | Rifampin
 | AR: androgen receptor | 0.22059 | Fluoxymesterone
 | 0.064846 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 513 | N | N | N | Loteprednol etabonate
 | RORA: RAR-related orphan receptor A | 0.36364 | Cholesterol
 | 0.061022 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 514 | N | N | N | Bicalutamide
 | ESRRA: estrogen-related receptor alpha | 0.36111 | Diethylstilbestrol
 | 0.12419 | AR: androgen receptor |
| 515 | N | N | N | Fluoxymesterone
 | RXRA: retinoid X receptor, alpha | 0.17949 | Tretinoin
 | 0.18294 | ESR1: estrogen receptor 1 |
| 516 | N | N | N | Progesterone
 | RXRA: retinoid X receptor, alpha | 0.18421 | Tretinoin
 | 0.18294 | ESR1: estrogen receptor 1 |
| 517 | N | N | N | Raloxifene hydrochloride
 | PGR: progesterone receptor | 0.19643 | Mifepristone
 | 0.13120 | ESR2: estrogen receptor 2 (ER beta) |
| 518 | N | N | N | Nandrolone phenpropionate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.24324 | Clofibrate
 | 0.061430 | AR: androgen receptor |
| 519 | N | N | N | Mometasone furoate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.15254 | Rosiglitazone maleate
 | 0.069755 | PGR: progesterone receptor |
| 520 | N | N | N | Mometasone furoate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.31818 | Pregnenolone
 | 0.066330 | PGR: progesterone receptor |
| 521 | N | N | N | Fenofibrate
 | RORB: RAR-related orphan receptor B | 0.42857 | Tazarotene
 | 0.17773 | PPARA: peroxisome proliferator-activated receptor alpha |
| 522 | N | N | N | Calcitriol
 | ESR2: estrogen receptor 2 (ER beta) | 0.28205 | Estradiol
 | 0.10255 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 523 | N | N | N | Ergocalciferol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.39024 | Chenodiol
 | 0.20226 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 524 | N | N | N | Hydrocortisone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.33333 | Calcitriol
 | 0.064100 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 525 | N | N | N | Raloxifene hydrochloride
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.30435 | Fenofibrate
 | 0.096117 | ESR2: estrogen receptor 2 (ER beta) |
| 526 | N | N | N | Eplerenone
 | RARA: retinoic acid receptor, alpha | 0.17021 | Tazarotene
 | 0.087093 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 527 | N | N | N | Budesonide
 | ESR2: estrogen receptor 2 (ER beta) | 0.27660 | Estramustine
 | 0.14446 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 528 | N | N | N | Dihydrotachysterol
 | RARG: retinoic acid receptor, gamma | 0.34210 | Tretinoin
 | 0.18311 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 529 | N | N | N | Norethindrone
 | RORA: RAR-related orphan receptor A | 0.42857 | Cholesterol
 | 0.057820 | PGR: progesterone receptor |
| 530 | N | N | N | Bicalutamide
 | ESRRG: estrogen-related receptor gamma | 0.36111 | Diethylstilbestrol
 | 0.11916 | AR: androgen receptor |
| 531 | N | N | N | Dihydrotachysterol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.37369 | Chenodiol
 | 0.20226 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 532 | N | N | N | Fenofibrate
 | RARG: retinoic acid receptor, gamma | 0.42857 | Tazarotene
 | 0.20327 | PPARA: peroxisome proliferator-activated receptor alpha |
| 533 | N | Y | N | Ethinyl estradiol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.32353 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
| 534 | N | N | N | Telmisartan
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.14516 | Mifepristone
 | 0.068035 | PPARG: peroxisome proliferator-activated receptor gamma |
| 535 | N | N | N | Telmisartan
 | ESRRG: estrogen-related receptor gamma | 0.28261 | Diethylstilbestrol
 | 0.14244 | PPARG: peroxisome proliferator-activated receptor gamma |
| 536 | N | N | N | Bicalutamide
 | ESRRB: estrogen-related receptor beta | 0.36111 | Diethylstilbestrol
 | 0.11072 | AR: androgen receptor |
| 537 | N | N | N | Spironolactone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.15909 | Tretinoin
 | 0.020347 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 538 | N | N | N | Estramustine
 | RARB: retinoic acid receptor, beta | 0.28571 | Tazarotene
 | 0.14884 | ESR1: estrogen receptor 1 |
| 539 | N | N | N | Nilutamide
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.20000 | Mifepristone
 | 0.23366 | AR: androgen receptor |
| 540 | N | N | N | Fenofibrate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.023810 | Palmitic acid
 | 0.13213 | PPARA: peroxisome proliferator-activated receptor alpha |
| 541 | N | N | N | Cholesterol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.046512 | Phenobarbital
 | 0.10498 | RORA: RAR-related orphan receptor A |
| 542 | N | N | N | Imatinib mesilate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.12903 | Cholecalciferol
 | 0.16329 | RORA: RAR-related orphan receptor A |
| 543 | N | N | N | Rosiglitazone maleate
 | ESRRG: estrogen-related receptor gamma | 0.29268 | Diethylstilbestrol
 | 0.14244 | PPARG: peroxisome proliferator-activated receptor gamma |
| 544 | N | N | N | Telmisartan
 | ESRRA: estrogen-related receptor alpha | 0.28261 | Diethylstilbestrol
 | 0.12835 | PPARG: peroxisome proliferator-activated receptor gamma |
| 545 | N | N | N | Rosiglitazone maleate
 | ESRRA: estrogen-related receptor alpha | 0.29268 | Diethylstilbestrol
 | 0.12835 | PPARG: peroxisome proliferator-activated receptor gamma |
| 546 | N | N | N | Eplerenone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.067797 | Rosiglitazone maleate
 | 0.066795 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 547 | N | N | N | Isotretinoin
 | PGR: progesterone receptor | 0.19048 | Medroxyprogesterone acetate
 | 0.084891 | RARA: retinoic acid receptor, alpha |
| 548 | N | N | N | Raloxifene hydrochloride
 | RXRA: retinoid X receptor, alpha | 0.30435 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
| 549 | N | N | N | Progesterone
 | RXRB: retinoid X receptor, beta | 0.18421 | Tretinoin
 | 0.16856 | ESR1: estrogen receptor 1 |
| 550 | N | N | N | Nilutamide
 | RARA: retinoic acid receptor, alpha | 0.20513 | Tazarotene
 | 0.087217 | AR: androgen receptor |
| 551 | N | N | N | Estradiol
 | RXRA: retinoid X receptor, alpha | 0.25000 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
| 552 | N | N | N | Fenofibrate
 | RXRA: retinoid X receptor, alpha | 0.42857 | Tazarotene
 | 0.17514 | PPARA: peroxisome proliferator-activated receptor alpha |
| 553 | N | N | N | Ergocalciferol
 | RARG: retinoic acid receptor, gamma | 0.34210 | Tretinoin
 | 0.18311 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 554 | N | N | N | Fenofibrate
 | RXRG: retinoid X receptor, gamma | 0.42857 | Tazarotene
 | 0.032006 | PPARA: peroxisome proliferator-activated receptor alpha |
| 555 | N | N | N | Dihydrotachysterol
 | RARB: retinoic acid receptor, beta | 0.34210 | Tretinoin
 | 0.18029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 556 | N | N | N | Paricalcitol
 | PGR: progesterone receptor | 0.35897 | Progesterone
 | 0.060029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 557 | N | N | N | Raloxifene hydrochloride
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.19512 | Butamben
 | 0.095273 | ESR1: estrogen receptor 1 |
| 558 | N | N | N | Estramustine
 | RARG: retinoic acid receptor, gamma | 0.28571 | Tazarotene
 | 0.14846 | ESR1: estrogen receptor 1 |
| 559 | N | N | N | Testosterone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.44118 | Chenodiol
 | 0.081683 | AR: androgen receptor |
| 560 | N | N | N | Ethinyl estradiol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.45946 | Mifepristone
 | 0.12027 | ESR1: estrogen receptor 1 |
| 561 | N | N | N | Ethynodiol diacetate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.32558 | Dihydrotachysterol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 562 | N | N | N | Etretinate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.13725 | Mifepristone
 | 0.11451 | RXRA: retinoid X receptor, alpha |
| 563 | N | N | N | Fluoxymesterone
 | RXRB: retinoid X receptor, beta | 0.17949 | Tretinoin
 | 0.16856 | ESR1: estrogen receptor 1 |
| 564 | N | N | N | Telmisartan
 | ESRRB: estrogen-related receptor beta | 0.28261 | Diethylstilbestrol
 | 0.12689 | PPARG: peroxisome proliferator-activated receptor gamma |
| 565 | N | N | N | Paricalcitol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10000 | Fenofibrate
 | 0.16326 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 566 | N | N | N | Rosiglitazone maleate
 | ESRRB: estrogen-related receptor beta | 0.29268 | Diethylstilbestrol
 | 0.12689 | PPARG: peroxisome proliferator-activated receptor gamma |
| 567 | N | N | N | Nilutamide
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.20000 | Butamben
 | 0.064846 | AR: androgen receptor |
| 568 | N | N | N | Dydrogesterone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.41667 | Chenodiol
 | 0.077571 | PGR: progesterone receptor |
| 569 | N | N | N | Raloxifene hydrochloride
 | RARA: retinoic acid receptor, alpha | 0.30435 | Tazarotene
 | 0.14896 | ESR2: estrogen receptor 2 (ER beta) |
| 570 | N | N | N | Rifampin
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.20270 | Eplerenone
 | 0.075614 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 572 | N | N | N | Ergocalciferol
 | RARB: retinoic acid receptor, beta | 0.34210 | Tretinoin
 | 0.18029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 573 | N | N | N | Bicalutamide
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.22857 | Butamben
 | 0.064846 | AR: androgen receptor |
| 574 | N | N | N | Paricalcitol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.33333 | Hydrocortisone
 | 0.064100 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 575 | N | N | N | Rifampin
 | RARB: retinoic acid receptor, beta | 0.19718 | Etretinate
 | 0.17437 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 576 | N | N | N | Paricalcitol
 | RORA: RAR-related orphan receptor A | 0.43232 | Cholesterol
 | 0.16329 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 577 | N | N | N | Calcitriol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10000 | Fenofibrate
 | 0.16326 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 578 | N | N | N | Budesonide
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.38461 | Pregnenolone
 | 0.071609 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 580 | N | N | N | Butamben
 | RXRG: retinoid X receptor, gamma | 0.34483 | Tazarotene
 | 0.048806 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 581 | N | N | N | Ethynodiol diacetate
 | RORB: RAR-related orphan receptor B | 0.20455 | Tazarotene
 | 0.090711 | ESR1: estrogen receptor 1 |
| 582 | N | N | N | Amcinonide
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.30612 | Chenodiol
 | 0.092251 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 583 | N | N | N | Rifampin
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.013158 | Palmitic acid
 | 0.11513 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 584 | N | N | N | Estradiol
 | RXRB: retinoid X receptor, beta | 0.25000 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
| 585 | N | Y | N | Estradiol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.38710 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
| 586 | N | N | N | Ethynodiol diacetate
 | RXRG: retinoid X receptor, gamma | 0.20455 | Tazarotene
 | 0.038684 | ESR1: estrogen receptor 1 |
| 587 | N | N | N | Raloxifene hydrochloride
 | RXRB: retinoid X receptor, beta | 0.30435 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
| 588 | N | N | N | Estrone sodium sulfate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.20455 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 589 | N | N | N | Rifampin
 | ESR1: estrogen receptor 1 | 0.22059 | Fluoxymesterone
 | 0.095273 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 590 | N | N | N | Isotretinoin
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.18421 | Pregnenolone
 | 0.16725 | RARA: retinoic acid receptor, alpha |
| 591 | Y | N | N | Bicalutamide
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.17308 | Mifepristone
 | 0.23366 | AR: androgen receptor |
| 592 | N | N | N | Budesonide
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10345 | Rosiglitazone maleate
 | 0.068035 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 593 | N | N | N | Mifepristone
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.37500 | Pregnenolone
 | 0.075614 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 594 | N | N | N | Amcinonide
 | ESR1: estrogen receptor 1 | 0.46342 | Fluoxymesterone
 | 0.13105 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 595 | N | N | N | Cholecalciferol
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.095238 | Palmitic acid
 | 0.11942 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 596 | N | N | N | Palmitic acid
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.021739 | Spironolactone
 | 0.082312 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 597 | N | N | N | Phenobarbital
 | RARA: retinoic acid receptor, alpha | 0.16667 | Tazarotene
 | 0.17500 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 598 | N | N | N | Rosiglitazone maleate
 | RORB: RAR-related orphan receptor B | 0.26087 | Tazarotene
 | 0.18625 | PPARG: peroxisome proliferator-activated receptor gamma |
| 599 | N | N | N | Flutamide
 | RORA: RAR-related orphan receptor A | 0.22000 | Imatinib mesilate
 | 0.055679 | AR: androgen receptor |
| 600 | N | N | N | Loteprednol etabonate
 | RXRG: retinoid X receptor, gamma | 0.18750 | Tazarotene
 | 0.042474 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 601 | N | N | N | Dienestrol
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.25926 | Butamben
 | 0.095273 | ESR1: estrogen receptor 1 |
| 602 | N | N | N | Telmisartan
 | RORC: RAR-related orphan receptor C | 0.10909 | Tretinoin
 | 0.15526 | PPARG: peroxisome proliferator-activated receptor gamma |
| 603 | N | N | N | Palmitic acid
 | AR: androgen receptor | 0.066667 | Nandrolone phenpropionate
 | 0.093100 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 604 | N | N | N | Butamben
 | RARB: retinoic acid receptor, beta | 0.34483 | Tazarotene
 | 0.17437 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 605 | N | N | N | Butamben
 | RORA: RAR-related orphan receptor A | 0.14286 | Imatinib mesilate
 | 0.13841 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 606 | N | N | N | Rosiglitazone maleate
 | RARB: retinoic acid receptor, beta | 0.26087 | Tazarotene
 | 0.20203 | PPARG: peroxisome proliferator-activated receptor gamma |
| 607 | N | N | N | Telmisartan
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.14516 | Mifepristone
 | 0.066795 | PPARG: peroxisome proliferator-activated receptor gamma |
| 608 | N | N | N | Medroxyprogesterone acetate
 | RXRG: retinoid X receptor, gamma | 0.19048 | Tretinoin
 | 0.035880 | PGR: progesterone receptor |
| 609 | N | N | N | Fenofibrate
 | RXRB: retinoid X receptor, beta | 0.42857 | Tazarotene
 | 0.14777 | PPARA: peroxisome proliferator-activated receptor alpha |
| 610 | N | N | N | Nandrolone phenpropionate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.23684 | Phenobarbital
 | 0.087787 | AR: androgen receptor |
| 611 | N | N | N | Isotretinoin
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.10909 | Telmisartan
 | 0.19466 | RARA: retinoic acid receptor, alpha |
| 612 | N | N | N | Etretinate
 | AR: androgen receptor | 0.15385 | Flutamide
 | 0.10468 | RXRA: retinoid X receptor, alpha |
| 613 | N | N | N | Calcitriol
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.090909 | Palmitic acid
 | 0.11942 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 614 | N | N | N | Norethindrone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.078431 | Rosiglitazone maleate
 | 0.069755 | PGR: progesterone receptor |
| 615 | N | N | N | Progesterone
 | RARA: retinoic acid receptor, alpha | 0.18421 | Tretinoin
 | 0.14052 | ESR1: estrogen receptor 1 |
| 616 | N | N | N | Flutamide
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.15909 | Mifepristone
 | 0.23366 | AR: androgen receptor |
| 617 | N | N | N | Fluoxymesterone
 | RARA: retinoic acid receptor, alpha | 0.17949 | Tretinoin
 | 0.14052 | ESR1: estrogen receptor 1 |
| 618 | N | N | N | Rifampin
 | RXRG: retinoid X receptor, gamma | 0.19718 | Etretinate
 | 0.048806 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 621 | N | N | N | Eplerenone
 | RXRG: retinoid X receptor, gamma | 0.17021 | Tazarotene
 | 0.035964 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 622 | N | N | N | Paricalcitol
 | RARG: retinoic acid receptor, gamma | 0.33333 | Tretinoin
 | 0.18311 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 625 | N | N | N | Telmisartan
 | RORB: RAR-related orphan receptor B | 0.23077 | Tazarotene
 | 0.18625 | PPARG: peroxisome proliferator-activated receptor gamma |
| 626 | N | N | N | Pregnenolone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.18421 | Tretinoin
 | 0.035170 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 627 | N | N | N | Isotretinoin
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.17391 | Mifepristone
 | 0.095668 | RARA: retinoic acid receptor, alpha |
| 628 | N | N | N | Calcitriol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.31915 | Mifepristone
 | 0.076190 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 629 | N | N | N | Dihydrotachysterol
 | RXRG: retinoid X receptor, gamma | 0.34210 | Tretinoin
 | 0.043160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 630 | N | N | N | Ergocalciferol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10204 | Fenofibrate
 | 0.16326 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 631 | N | N | N | Budesonide
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.31111 | Chenodiol
 | 0.092251 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 632 | Y | N | N | Rosiglitazone maleate
 | RARG: retinoic acid receptor, gamma | 0.26087 | Tazarotene
 | 0.19825 | PPARG: peroxisome proliferator-activated receptor gamma |
| 633 | N | N | N | Mometasone furoate
 | RARA: retinoic acid receptor, alpha | 0.22449 | Tazarotene
 | 0.084891 | PGR: progesterone receptor |
| 634 | N | N | N | Flutamide
 | ESR2: estrogen receptor 2 (ER beta) | 0.23077 | Estramustine
 | 0.11996 | AR: androgen receptor |
| 635 | N | N | N | Cholecalciferol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10417 | Fenofibrate
 | 0.16326 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 636 | N | N | N | Clomiphene citrate
 | RARA: retinoic acid receptor, alpha | 0.21818 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
| 637 | N | N | N | Rifampin
 | PGR: progesterone receptor | 0.25186 | Medroxyprogesterone acetate
 | 0.066330 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 638 | N | N | N | Amcinonide
 | RORA: RAR-related orphan receptor A | 0.30612 | Cholesterol
 | 0.061022 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 639 | N | N | N | Ergocalciferol
 | RORC: RAR-related orphan receptor C | 0.34210 | Tretinoin
 | 0.14372 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 640 | N | N | N | Dihydrotachysterol
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.10204 | Fenofibrate
 | 0.16326 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 641 | N | N | N | Clofibrate
 | RORB: RAR-related orphan receptor B | 0.41379 | Tazarotene
 | 0.17773 | PPARA: peroxisome proliferator-activated receptor alpha |
| 642 | N | N | N | Flutamide
 | RARA: retinoic acid receptor, alpha | 0.22222 | Tazarotene
 | 0.087217 | AR: androgen receptor |
| 643 | N | N | N | Loteprednol etabonate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.063830 | Palmitic acid
 | 0.10292 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 644 | N | N | N | Paricalcitol
 | RARB: retinoic acid receptor, beta | 0.33333 | Tretinoin
 | 0.18029 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 645 | N | N | N | Eplerenone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.15556 | Tretinoin
 | 0.020347 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 646 | N | N | N | Clofibrate
 | ESRRG: estrogen-related receptor gamma | 0.33333 | Diethylstilbestrol
 | 0.14241 | PPARA: peroxisome proliferator-activated receptor alpha |
| 647 | N | N | N | Raloxifene hydrochloride
 | AR: androgen receptor | 0.33333 | Bicalutamide
 | 0.11996 | ESR2: estrogen receptor 2 (ER beta) |
| 648 | N | N | N | Cholesterol
 | RARA: retinoic acid receptor, alpha | 0.19048 | Tretinoin
 | 0.15182 | RORA: RAR-related orphan receptor A |
| 649 | N | N | N | Dihydrotachysterol
 | RXRA: retinoid X receptor, alpha | 0.34210 | Tretinoin
 | 0.13066 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 650 | N | N | N | Imatinib mesilate
 | ESRRA: estrogen-related receptor alpha | 0.25265 | Diethylstilbestrol
 | 0.094996 | RORA: RAR-related orphan receptor A |
| 651 | N | N | N | Clomiphene citrate
 | RORA: RAR-related orphan receptor A | 0.22634 | Imatinib mesilate
 | 0.085339 | ESR1: estrogen receptor 1 |
| 652 | N | N | N | Estradiol
 | RARA: retinoic acid receptor, alpha | 0.25000 | Tazarotene
 | 0.14896 | ESR2: estrogen receptor 2 (ER beta) |
| 653 | N | N | N | Chenodiol
 | RARB: retinoic acid receptor, beta | 0.21951 | Tretinoin
 | 0.19755 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 654 | N | N | N | Estradiol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.33333 | Chenodiol
 | 0.12692 | ESR2: estrogen receptor 2 (ER beta) |
| 655 | N | N | N | Estrone sodium sulfate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.26316 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
| 656 | N | N | N | Clofibrate
 | PGR: progesterone receptor | 0.23077 | Mifepristone
 | 0.059277 | PPARA: peroxisome proliferator-activated receptor alpha |
| 657 | N | N | N | Flutamide
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.15909 | Mifepristone
 | 0.20529 | AR: androgen receptor |
| 658 | N | N | N | Raloxifene hydrochloride
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.19643 | Mifepristone
 | 0.14446 | ESR2: estrogen receptor 2 (ER beta) |
| 659 | N | N | N | Hydrocortisone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.047619 | Palmitic acid
 | 0.10292 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 660 | N | N | N | Dihydrotachysterol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.068966 | Rosiglitazone maleate
 | 0.18238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 661 | N | N | N | Hydrocortisone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.10256 | Phenobarbital
 | 0.10736 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 662 | N | N | N | Ergocalciferol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.068966 | Rosiglitazone maleate
 | 0.18238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 663 | N | N | N | Rosiglitazone maleate
 | RORC: RAR-related orphan receptor C | 0.10000 | Tretinoin
 | 0.15526 | PPARG: peroxisome proliferator-activated receptor gamma |
| 664 | N | N | N | Fenofibrate
 | PGR: progesterone receptor | 0.22449 | Mometasone furoate
 | 0.059277 | PPARA: peroxisome proliferator-activated receptor alpha |
| 665 | N | N | N | Clofibrate
 | ESR2: estrogen receptor 2 (ER beta) | 0.33333 | Diethylstilbestrol
 | 0.096117 | PPARA: peroxisome proliferator-activated receptor alpha |
| 666 | N | N | N | Ergocalciferol
 | RXRG: retinoid X receptor, gamma | 0.34210 | Tretinoin
 | 0.043160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 667 | N | N | N | Estramustine
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.32609 | Mifepristone
 | 0.12278 | ESR2: estrogen receptor 2 (ER beta) |
| 669 | N | N | N | Estrone sodium sulfate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.20833 | Rosiglitazone maleate
 | 0.10925 | ESR1: estrogen receptor 1 |
| 670 | N | N | N | Loteprednol etabonate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.27660 | Cholecalciferol
 | 0.064100 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 671 | N | N | N | Imatinib mesilate
 | ESRRB: estrogen-related receptor beta | 0.25265 | Diethylstilbestrol
 | 0.091736 | RORA: RAR-related orphan receptor A |
| 672 | N | N | N | Estrone sodium sulfate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.20588 | Clofibrate
 | 0.092842 | ESR1: estrogen receptor 1 |
| 673 | N | N | N | Cholecalciferol
 | RARA: retinoic acid receptor, alpha | 0.25000 | Tretinoin
 | 0.17498 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 674 | N | N | N | Rosiglitazone maleate
 | ESR2: estrogen receptor 2 (ER beta) | 0.29268 | Diethylstilbestrol
 | 0.094479 | PPARG: peroxisome proliferator-activated receptor gamma |
| 675 | N | N | N | Medroxyprogesterone acetate
 | RXRB: retinoid X receptor, beta | 0.19048 | Tretinoin
 | 0.096643 | PGR: progesterone receptor |
| 676 | N | N | N | Estradiol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.40541 | Mifepristone
 | 0.12278 | ESR2: estrogen receptor 2 (ER beta) |
| 677 | N | N | N | Estrone
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.40541 | Mifepristone
 | 0.13105 | ESR1: estrogen receptor 1 |
| 678 | N | N | N | Progesterone
 | RARG: retinoic acid receptor, gamma | 0.18421 | Tretinoin
 | 0.14846 | ESR1: estrogen receptor 1 |
| 679 | N | N | N | Estramustine
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.26667 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 680 | N | N | N | Levonorgestrel
 | RXRA: retinoid X receptor, alpha | 0.12500 | Tretinoin
 | 0.18294 | ESR1: estrogen receptor 1 |
| 681 | N | N | N | Norgestrel
 | RXRA: retinoid X receptor, alpha | 0.12500 | Tretinoin
 | 0.18294 | ESR1: estrogen receptor 1 |
| 682 | N | N | N | Estrone
 | RORA: RAR-related orphan receptor A | 0.29730 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
| 683 | Y | N | N | Rosiglitazone maleate
 | RXRA: retinoid X receptor, alpha | 0.26087 | Tazarotene
 | 0.17057 | PPARG: peroxisome proliferator-activated receptor gamma |
| 684 | N | N | N | Estrone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.23333 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
| 685 | N | N | N | Clomiphene citrate
 | AR: androgen receptor | 0.24561 | Bicalutamide
 | 0.11924 | ESR1: estrogen receptor 1 |
| 686 | N | N | N | Nandrolone phenpropionate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.18868 | Rosiglitazone maleate
 | 0.063846 | AR: androgen receptor |
| 687 | N | N | N | Pregnenolone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.025000 | Palmitic acid
 | 0.11513 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 688 | N | N | N | Fluoxymesterone
 | RARG: retinoic acid receptor, gamma | 0.17949 | Tretinoin
 | 0.14846 | ESR1: estrogen receptor 1 |
| 689 | N | N | N | Nandrolone phenpropionate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.34884 | Chenodiol
 | 0.081683 | AR: androgen receptor |
| 690 | N | N | N | Spironolactone
 | RORC: RAR-related orphan receptor C | 0.15909 | Tretinoin
 | 0.064847 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 691 | N | N | N | Rifampin
 | RORC: RAR-related orphan receptor C | 0.12500 | Tretinoin
 | 0.15608 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 692 | N | N | N | Mometasone furoate
 | ESR2: estrogen receptor 2 (ER beta) | 0.36170 | Estramustine
 | 0.13120 | PGR: progesterone receptor |
| 693 | N | N | N | Medroxyprogesterone acetate
 | RXRA: retinoid X receptor, alpha | 0.19048 | Tretinoin
 | 0.10416 | PGR: progesterone receptor |
| 694 | N | N | N | Ergocalciferol
 | RXRA: retinoid X receptor, alpha | 0.34210 | Tretinoin
 | 0.13066 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 695 | N | N | N | Loteprednol etabonate
 | RXRA: retinoid X receptor, alpha | 0.18750 | Tazarotene
 | 0.11451 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 696 | N | N | N | Levonorgestrel
 | ESRRB: estrogen-related receptor beta | 0.075000 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
| 697 | N | N | N | Norgestrel
 | ESRRB: estrogen-related receptor beta | 0.075000 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
| 698 | N | N | N | Rifampin
 | RARG: retinoic acid receptor, gamma | 0.19718 | Etretinate
 | 0.16039 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 699 | N | N | N | Etretinate
 | PGR: progesterone receptor | 0.14894 | Medroxyprogesterone acetate
 | 0.10416 | RXRA: retinoid X receptor, alpha |
| 700 | N | N | N | Dydrogesterone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.076923 | Rosiglitazone maleate
 | 0.069755 | PGR: progesterone receptor |
| 701 | N | N | N | Amcinonide
 | RARA: retinoic acid receptor, alpha | 0.15094 | Tazarotene
 | 0.095668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 703 | N | N | N | Isotretinoin
 | ESR1: estrogen receptor 1 | 0.18421 | Progesterone
 | 0.14052 | RARA: retinoic acid receptor, alpha |
| 704 | N | N | N | Imatinib mesilate
 | RARB: retinoic acid receptor, beta | 0.31372 | Tazarotene
 | 0.17163 | RORA: RAR-related orphan receptor A |
| 706 | N | N | N | Paricalcitol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.33333 | Tretinoin
 | 0.037160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 707 | N | N | N | Flutamide
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.13725 | Telmisartan
 | 0.063846 | AR: androgen receptor |
| 708 | N | N | N | Cholecalciferol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.33333 | Mifepristone
 | 0.076190 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 709 | N | N | N | Etretinate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.13725 | Mifepristone
 | 0.095503 | RARG: retinoic acid receptor, gamma |
| 710 | N | N | N | Loteprednol etabonate
 | RXRB: retinoid X receptor, beta | 0.18750 | Tazarotene
 | 0.10128 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 711 | N | N | N | Dihydrotachysterol
 | RXRB: retinoid X receptor, beta | 0.34210 | Tretinoin
 | 0.10984 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 712 | N | N | N | Budesonide
 | ESRRG: estrogen-related receptor gamma | 0.10870 | Diethylstilbestrol
 | 0.16148 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 713 | N | N | N | Imatinib mesilate
 | ESRRG: estrogen-related receptor gamma | 0.25265 | Diethylstilbestrol
 | 0.094696 | RORA: RAR-related orphan receptor A |
| 714 | N | N | N | Estramustine
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.25000 | Clofibrate
 | 0.096117 | ESR2: estrogen receptor 2 (ER beta) |
| 715 | N | N | N | Ergocalciferol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.34210 | Tretinoin
 | 0.037160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 716 | N | N | N | Paricalcitol
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.067797 | Rosiglitazone maleate
 | 0.18238 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 717 | N | N | N | Cholecalciferol
 | ESR2: estrogen receptor 2 (ER beta) | 0.29730 | Estradiol
 | 0.10255 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 718 | N | N | N | Paricalcitol
 | RORC: RAR-related orphan receptor C | 0.33333 | Tretinoin
 | 0.14372 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 719 | N | N | N | Clofibrate
 | ESRRB: estrogen-related receptor beta | 0.33333 | Diethylstilbestrol
 | 0.12375 | PPARA: peroxisome proliferator-activated receptor alpha |
| 720 | N | N | N | Butamben
 | RXRB: retinoid X receptor, beta | 0.34483 | Tazarotene
 | 0.11677 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 721 | N | N | N | Estramustine
 | RXRG: retinoid X receptor, gamma | 0.28571 | Tazarotene
 | 0.038684 | ESR1: estrogen receptor 1 |
| 722 | N | N | N | Progesterone
 | RARB: retinoic acid receptor, beta | 0.18421 | Tretinoin
 | 0.14884 | ESR1: estrogen receptor 1 |
| 723 | N | N | N | Loteprednol etabonate
 | ESR2: estrogen receptor 2 (ER beta) | 0.38636 | Estramustine
 | 0.14446 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 724 | N | N | N | Phenobarbital
 | ESR2: estrogen receptor 2 (ER beta) | 0.23333 | Diethylstilbestrol
 | 0.13704 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 725 | N | N | N | Loteprednol etabonate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.30435 | Chenodiol
 | 0.092251 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 726 | N | N | N | Fluoxymesterone
 | RARB: retinoic acid receptor, beta | 0.17949 | Tretinoin
 | 0.14884 | ESR1: estrogen receptor 1 |
| 727 | N | N | N | Medroxyprogesterone acetate
 | RARG: retinoic acid receptor, gamma | 0.19048 | Tretinoin
 | 0.087116 | PGR: progesterone receptor |
| 728 | N | N | N | Butamben
 | RARG: retinoic acid receptor, gamma | 0.34483 | Tazarotene
 | 0.16039 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 729 | N | N | N | Spironolactone
 | ESRRA: estrogen-related receptor alpha | 0.042553 | Diethylstilbestrol
 | 0.13692 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 730 | N | N | N | Budesonide
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.090909 | Phenobarbital
 | 0.10736 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 731 | N | N | N | Estramustine
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.29546 | Chenodiol
 | 0.12692 | ESR2: estrogen receptor 2 (ER beta) |
| 732 | N | N | N | Chenodiol
 | RARG: retinoic acid receptor, gamma | 0.21951 | Tretinoin
 | 0.19161 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 733 | N | N | N | Pregnenolone
 | RORB: RAR-related orphan receptor B | 0.18421 | Tretinoin
 | 0.14754 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 734 | N | N | N | Dihydrotachysterol
 | RORC: RAR-related orphan receptor C | 0.34210 | Tretinoin
 | 0.14372 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 735 | N | N | N | Fluoxymesterone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.40541 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
| 736 | N | N | N | Ergocalciferol
 | RORB: RAR-related orphan receptor B | 0.34210 | Tretinoin
 | 0.16115 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 737 | N | N | N | Ethynodiol diacetate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.45714 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
| 738 | N | N | N | Fluoxymesterone
 | RORC: RAR-related orphan receptor C | 0.17949 | Tretinoin
 | 0.081057 | ESR1: estrogen receptor 1 |
| 740 | N | N | N | Rosiglitazone maleate
 | RXRG: retinoid X receptor, gamma | 0.26087 | Tazarotene
 | 0.029508 | PPARG: peroxisome proliferator-activated receptor gamma |
| 741 | N | N | N | Imatinib mesilate
 | RXRG: retinoid X receptor, gamma | 0.31372 | Tazarotene
 | 0.038021 | RORA: RAR-related orphan receptor A |
| 742 | N | N | N | Dydrogesterone
 | RARA: retinoic acid receptor, alpha | 0.18421 | Tretinoin
 | 0.084891 | PGR: progesterone receptor |
| 743 | N | N | N | Pregnenolone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.090909 | Fenofibrate
 | 0.14611 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 744 | N | N | N | Paricalcitol
 | RXRG: retinoid X receptor, gamma | 0.33333 | Tretinoin
 | 0.043160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 745 | N | N | N | Hydrocortisone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.092593 | Rosiglitazone maleate
 | 0.068035 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 746 | N | N | N | Amcinonide
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.038462 | Palmitic acid
 | 0.10292 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 747 | N | N | N | Nilutamide
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.025641 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
| 748 | N | N | N | Raloxifene hydrochloride
 | RARB: retinoic acid receptor, beta | 0.30435 | Tazarotene
 | 0.14884 | ESR1: estrogen receptor 1 |
| 749 | N | N | N | Norethindrone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.025641 | Palmitic acid
 | 0.097154 | PGR: progesterone receptor |
| 750 | N | N | N | Fulvestrant
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.23729 | Mifepristone
 | 0.14446 | ESR2: estrogen receptor 2 (ER beta) |
| 751 | N | N | N | Levonorgestrel
 | RXRB: retinoid X receptor, beta | 0.12500 | Tretinoin
 | 0.16856 | ESR1: estrogen receptor 1 |
| 752 | N | N | N | Norgestrel
 | RXRB: retinoid X receptor, beta | 0.12500 | Tretinoin
 | 0.16856 | ESR1: estrogen receptor 1 |
| 753 | N | N | N | Telmisartan
 | RARB: retinoic acid receptor, beta | 0.23077 | Tazarotene
 | 0.20203 | PPARG: peroxisome proliferator-activated receptor gamma |
| 754 | N | N | N | Dihydrotachysterol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.34210 | Tretinoin
 | 0.037160 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 755 | N | N | N | Bicalutamide
 | RARA: retinoic acid receptor, alpha | 0.31707 | Tazarotene
 | 0.087217 | AR: androgen receptor |
| 756 | N | N | N | Loteprednol etabonate
 | RARB: retinoic acid receptor, beta | 0.18750 | Tazarotene
 | 0.096751 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 757 | N | N | N | Rifampin
 | RXRB: retinoid X receptor, beta | 0.19718 | Etretinate
 | 0.11677 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 758 | N | N | N | Ethinyl estradiol
 | RORA: RAR-related orphan receptor A | 0.28205 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
| 759 | N | N | N | Ergocalciferol
 | RXRB: retinoid X receptor, beta | 0.34210 | Tretinoin
 | 0.10984 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 760 | N | N | N | Estradiol
 | RARB: retinoic acid receptor, beta | 0.25000 | Tazarotene
 | 0.14884 | ESR1: estrogen receptor 1 |
| 761 | N | N | N | Butamben
 | RXRA: retinoid X receptor, alpha | 0.34483 | Tazarotene
 | 0.12632 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 762 | N | N | N | Fulvestrant
 | RXRA: retinoid X receptor, alpha | 0.17857 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
| 763 | N | N | N | Rosiglitazone maleate
 | RXRB: retinoid X receptor, beta | 0.26087 | Tazarotene
 | 0.14366 | PPARG: peroxisome proliferator-activated receptor gamma |
| 764 | N | N | N | Estramustine
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.26829 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
| 765 | N | N | N | Norethindrone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.11429 | Phenobarbital
 | 0.092601 | PGR: progesterone receptor |
| 766 | N | N | N | Amcinonide
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.081633 | Phenobarbital
 | 0.10736 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 767 | N | N | N | Chenodiol
 | RXRG: retinoid X receptor, gamma | 0.21951 | Tretinoin
 | 0.036481 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 768 | N | N | N | Pregnenolone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.050847 | Telmisartan
 | 0.16215 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 769 | N | N | N | Loteprednol etabonate
 | RARG: retinoic acid receptor, gamma | 0.18750 | Tazarotene
 | 0.099896 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 770 | N | N | N | Hydrocortisone
 | ESRRG: estrogen-related receptor gamma | 0.095238 | Diethylstilbestrol
 | 0.16148 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 771 | N | N | N | Budesonide
 | ESRRA: estrogen-related receptor alpha | 0.10870 | Diethylstilbestrol
 | 0.15441 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 772 | N | N | N | Raloxifene hydrochloride
 | RORB: RAR-related orphan receptor B | 0.30435 | Tazarotene
 | 0.095294 | ESR2: estrogen receptor 2 (ER beta) |
| 773 | N | N | N | Rosiglitazone maleate
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.10000 | Tretinoin
 | 0.028455 | PPARG: peroxisome proliferator-activated receptor gamma |
| 775 | N | N | N | Estrone sodium sulfate
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.35714 | Mifepristone
 | 0.12027 | ESR1: estrogen receptor 1 |
| 776 | N | N | N | Fulvestrant
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.23729 | Mifepristone
 | 0.12278 | ESR2: estrogen receptor 2 (ER beta) |
| 777 | N | N | N | Paricalcitol
 | RXRA: retinoid X receptor, alpha | 0.33333 | Tretinoin
 | 0.13066 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 778 | N | N | N | Desogestrel
 | RXRA: retinoid X receptor, alpha | 0.12500 | Tretinoin
 | 0.18294 | ESR1: estrogen receptor 1 |
| 779 | N | N | N | Estramustine
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.11905 | Palmitic acid
 | 0.14814 | ESR2: estrogen receptor 2 (ER beta) |
| 780 | N | N | N | Loteprednol etabonate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.083333 | Rosiglitazone maleate
 | 0.068035 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 781 | N | N | N | Estrone sodium sulfate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.20000 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
| 782 | N | N | N | Medroxyprogesterone acetate
 | RARB: retinoic acid receptor, beta | 0.19048 | Tretinoin
 | 0.078278 | PGR: progesterone receptor |
| 783 | N | N | N | Estradiol
 | RARG: retinoic acid receptor, gamma | 0.25000 | Tazarotene
 | 0.14846 | ESR1: estrogen receptor 1 |
| 784 | N | N | N | Raloxifene hydrochloride
 | RARG: retinoic acid receptor, gamma | 0.30435 | Tazarotene
 | 0.14846 | ESR1: estrogen receptor 1 |
| 785 | N | N | N | Dydrogesterone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.090909 | Fenofibrate
 | 0.059277 | PGR: progesterone receptor |
| 786 | N | N | N | Fulvestrant
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.23077 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
| 787 | N | N | N | Fluoxymesterone
 | RORB: RAR-related orphan receptor B | 0.17949 | Tretinoin
 | 0.090711 | ESR1: estrogen receptor 1 |
| 788 | N | N | N | Ergocalciferol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.32609 | Mifepristone
 | 0.076190 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 789 | N | N | N | Flutamide
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.068182 | Cholecalciferol
 | 0.067869 | AR: androgen receptor |
| 790 | N | N | N | Budesonide
 | ESRRB: estrogen-related receptor beta | 0.10870 | Diethylstilbestrol
 | 0.14423 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 791 | N | N | N | Norethindrone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.35135 | Chenodiol
 | 0.077571 | PGR: progesterone receptor |
| 792 | N | N | N | Pregnenolone
 | RARA: retinoic acid receptor, alpha | 0.18421 | Tretinoin
 | 0.16725 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 793 | N | N | N | Flutamide
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.027778 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
| 794 | N | N | N | Dienestrol
 | RARA: retinoic acid receptor, alpha | 0.36364 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
| 795 | N | N | N | Progesterone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.45714 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
| 796 | N | N | N | Cholesterol
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.19048 | Tretinoin
 | 0.017933 | RORA: RAR-related orphan receptor A |
| 797 | N | N | N | Desogestrel
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.34210 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
| 798 | N | N | N | Progesterone
 | RORB: RAR-related orphan receptor B | 0.18421 | Tretinoin
 | 0.090711 | ESR1: estrogen receptor 1 |
| 799 | N | N | N | Telmisartan
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.10909 | Tretinoin
 | 0.028455 | PPARG: peroxisome proliferator-activated receptor gamma |
| 800 | N | N | N | Imatinib mesilate
 | RARG: retinoic acid receptor, gamma | 0.31372 | Tazarotene
 | 0.16278 | RORA: RAR-related orphan receptor A |
| 801 | N | N | N | Levonorgestrel
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.14286 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
| 802 | N | N | N | Norgestrel
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.14286 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
| 803 | N | N | N | Oxandrolone
 | RARA: retinoic acid receptor, alpha | 0.15790 | Tretinoin
 | 0.087217 | AR: androgen receptor |
| 804 | N | N | N | Estrone
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.20455 | Rosiglitazone maleate
 | 0.10925 | ESR1: estrogen receptor 1 |
| 805 | N | N | N | Desogestrel
 | ESRRB: estrogen-related receptor beta | 0.075000 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
| 806 | N | N | N | Fluoxymesterone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.17949 | Tretinoin
 | 0.026027 | ESR1: estrogen receptor 1 |
| 807 | N | N | N | Telmisartan
 | RARG: retinoic acid receptor, gamma | 0.23077 | Tazarotene
 | 0.19825 | PPARG: peroxisome proliferator-activated receptor gamma |
| 808 | N | N | N | Clomiphene citrate
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.19149 | Butamben
 | 0.095273 | ESR1: estrogen receptor 1 |
| 809 | N | N | N | Calcitriol
 | RARA: retinoic acid receptor, alpha | 0.23810 | Tretinoin
 | 0.17498 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 810 | N | N | N | Estradiol
 | RORA: RAR-related orphan receptor A | 0.33333 | Cholesterol
 | 0.088647 | ESR2: estrogen receptor 2 (ER beta) |
| 811 | N | N | N | Ethinyl estradiol
 | RARA: retinoic acid receptor, alpha | 0.27027 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
| 812 | N | N | N | Flutamide
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.16129 | Phenobarbital
 | 0.087787 | AR: androgen receptor |
| 813 | N | N | N | Budesonide
 | RARA: retinoic acid receptor, alpha | 0.15217 | Tretinoin
 | 0.095668 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 814 | N | N | N | Desogestrel
 | NR1I2: nuclear receptor subfamily 1, group I, member 2 | 0.43750 | Pregnenolone
 | 0.095273 | ESR1: estrogen receptor 1 |
| 815 | N | N | N | Clofibrate
 | ESRRA: estrogen-related receptor alpha | 0.33333 | Diethylstilbestrol
 | 0.11006 | PPARA: peroxisome proliferator-activated receptor alpha |
| 816 | N | N | N | Hydrocortisone
 | ESRRA: estrogen-related receptor alpha | 0.095238 | Diethylstilbestrol
 | 0.15441 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 817 | N | N | N | Desogestrel
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.051282 | Palmitic acid
 | 0.14077 | ESR1: estrogen receptor 1 |
| 818 | N | N | N | Ergocalciferol
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.32609 | Mifepristone
 | 0.064100 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 819 | N | N | N | Fulvestrant
 | RXRB: retinoid X receptor, beta | 0.17857 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
| 820 | N | N | N | Isotretinoin
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.093023 | Fenofibrate
 | 0.20153 | RARA: retinoic acid receptor, alpha |
| 821 | N | N | N | Spironolactone
 | ESRRG: estrogen-related receptor gamma | 0.042553 | Diethylstilbestrol
 | 0.13025 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 822 | N | N | N | Rifampin
 | RXRA: retinoid X receptor, alpha | 0.19718 | Etretinate
 | 0.12632 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 823 | N | N | N | Eplerenone
 | RORC: RAR-related orphan receptor C | 0.15556 | Tretinoin
 | 0.064847 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 824 | N | N | N | Budesonide
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.15217 | Tretinoin
 | 0.019114 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 825 | N | N | N | Estradiol
 | RORB: RAR-related orphan receptor B | 0.25000 | Tazarotene
 | 0.095294 | ESR2: estrogen receptor 2 (ER beta) |
| 826 | N | N | N | Estrone
 | RARA: retinoic acid receptor, alpha | 0.25000 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
| 827 | N | N | N | Rosiglitazone maleate
 | PGR: progesterone receptor | 0.18182 | Mifepristone
 | 0.069755 | PPARG: peroxisome proliferator-activated receptor gamma |
| 828 | N | N | N | Tazarotene
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.10417 | Cholecalciferol
 | 0.18311 | RARG: retinoic acid receptor, gamma |
| 829 | N | N | N | Mometasone furoate
 | RXRG: retinoid X receptor, gamma | 0.22449 | Tazarotene
 | 0.035880 | PGR: progesterone receptor |
| 830 | N | N | N | Nandrolone phenpropionate
 | RARA: retinoic acid receptor, alpha | 0.25000 | Tazarotene
 | 0.087217 | AR: androgen receptor |
| 831 | N | N | N | Ethynodiol diacetate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.36585 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
| 832 | N | N | N | Estramustine
 | RORB: RAR-related orphan receptor B | 0.28571 | Tazarotene
 | 0.095294 | ESR2: estrogen receptor 2 (ER beta) |
| 833 | N | N | N | Hydrocortisone
 | ESR2: estrogen receptor 2 (ER beta) | 0.35294 | Estradiol
 | 0.14446 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 834 | N | N | N | Bicalutamide
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.044444 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
| 835 | N | N | N | Dydrogesterone
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.11111 | Phenobarbital
 | 0.092601 | PGR: progesterone receptor |
| 836 | N | N | N | Nilutamide
 | RXRA: retinoid X receptor, alpha | 0.20513 | Tazarotene
 | 0.10468 | AR: androgen receptor |
| 837 | N | N | N | Paricalcitol
 | RXRB: retinoid X receptor, beta | 0.33333 | Tretinoin
 | 0.10984 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 838 | N | N | N | Estrone sodium sulfate
 | RARA: retinoic acid receptor, alpha | 0.21951 | Tazarotene
 | 0.14052 | ESR1: estrogen receptor 1 |
| 839 | N | N | N | Hydrocortisone
 | ESRRB: estrogen-related receptor beta | 0.095238 | Diethylstilbestrol
 | 0.14423 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 840 | N | N | N | Oxandrolone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.025641 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
| 841 | N | N | N | Loteprednol etabonate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.088889 | Phenobarbital
 | 0.10736 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 842 | N | N | N | Progesterone
 | RXRG: retinoid X receptor, gamma | 0.18421 | Tretinoin
 | 0.038684 | ESR1: estrogen receptor 1 |
| 843 | N | N | N | Eplerenone
 | RARG: retinoic acid receptor, gamma | 0.17021 | Tazarotene
 | 0.095503 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 844 | N | N | N | Levonorgestrel
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.051282 | Palmitic acid
 | 0.14077 | ESR1: estrogen receptor 1 |
| 845 | N | N | N | Norgestrel
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.051282 | Palmitic acid
 | 0.14077 | ESR1: estrogen receptor 1 |
| 846 | N | N | N | Nandrolone phenpropionate
 | RXRG: retinoid X receptor, gamma | 0.25000 | Tazarotene
 | 0.028328 | AR: androgen receptor |
| 847 | N | N | N | Oxandrolone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.15790 | Tretinoin
 | 0.019212 | AR: androgen receptor |
| 848 | N | N | N | Amcinonide
 | RXRG: retinoid X receptor, gamma | 0.15094 | Tazarotene
 | 0.042474 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 849 | N | N | N | Desogestrel
 | RXRB: retinoid X receptor, beta | 0.12500 | Tretinoin
 | 0.16856 | ESR1: estrogen receptor 1 |
| 850 | N | N | N | Nilutamide
 | RXRG: retinoid X receptor, gamma | 0.20513 | Tazarotene
 | 0.028328 | AR: androgen receptor |
| 851 | N | N | N | Amcinonide
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.078125 | Rosiglitazone maleate
 | 0.068035 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 852 | N | N | N | Hydrocortisone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.085106 | Fenofibrate
 | 0.077024 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 853 | N | N | N | Progesterone
 | RORC: RAR-related orphan receptor C | 0.18421 | Tretinoin
 | 0.081057 | ESR1: estrogen receptor 1 |
| 854 | N | N | N | Mometasone furoate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.15556 | Phenobarbital
 | 0.092601 | PGR: progesterone receptor |
| 855 | N | N | N | Eplerenone
 | RORB: RAR-related orphan receptor B | 0.17021 | Tazarotene
 | 0.071358 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 856 | N | N | N | Nandrolone phenpropionate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.066667 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
| 857 | N | N | N | Spironolactone
 | ESRRB: estrogen-related receptor beta | 0.042553 | Diethylstilbestrol
 | 0.11497 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 859 | N | N | N | Butamben
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.17949 | Mifepristone
 | 0.071609 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 860 | N | N | N | Mometasone furoate
 | RORA: RAR-related orphan receptor A | 0.26000 | Cholesterol
 | 0.057820 | PGR: progesterone receptor |
| 861 | N | N | N | Nilutamide
 | RXRB: retinoid X receptor, beta | 0.20513 | Tazarotene
 | 0.093636 | AR: androgen receptor |
| 863 | N | N | N | Fluoxymesterone
 | ESRRB: estrogen-related receptor beta | 0.10000 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
| 864 | N | N | N | Telmisartan
 | RXRA: retinoid X receptor, alpha | 0.23077 | Tazarotene
 | 0.17057 | PPARG: peroxisome proliferator-activated receptor gamma |
| 865 | N | N | N | Phenobarbital
 | RORB: RAR-related orphan receptor B | 0.16667 | Tazarotene
 | 0.11617 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 866 | N | N | N | Ethinyl estradiol
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.31579 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
| 867 | N | N | N | Budesonide
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.098039 | Fenofibrate
 | 0.077024 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 868 | N | N | N | Spironolactone
 | RARA: retinoic acid receptor, alpha | 0.15909 | Tretinoin
 | 0.087093 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 869 | N | N | N | Bicalutamide
 | RXRA: retinoid X receptor, alpha | 0.31707 | Tazarotene
 | 0.10468 | AR: androgen receptor |
| 870 | N | N | N | Isotretinoin
 | RORA: RAR-related orphan receptor A | 0.19048 | Cholesterol
 | 0.15182 | RARA: retinoic acid receptor, alpha |
| 871 | N | N | N | Ethynodiol diacetate
 | RORA: RAR-related orphan receptor A | 0.40000 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
| 872 | N | N | N | Paricalcitol
 | RORB: RAR-related orphan receptor B | 0.33333 | Tretinoin
 | 0.16115 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 873 | N | N | N | Paricalcitol
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.29167 | Mifepristone
 | 0.076190 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 874 | N | N | N | Cholesterol
 | ESR2: estrogen receptor 2 (ER beta) | 0.33333 | Estradiol
 | 0.088647 | RORA: RAR-related orphan receptor A |
| 875 | N | N | N | Rifampin
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.12500 | Tretinoin
 | 0.035170 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 876 | N | N | N | Estradiol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.15625 | Phenobarbital
 | 0.13704 | ESR2: estrogen receptor 2 (ER beta) |
| 877 | N | N | N | Flutamide
 | RXRA: retinoid X receptor, alpha | 0.22222 | Tazarotene
 | 0.10468 | AR: androgen receptor |
| 878 | N | N | N | Nilutamide
 | RARG: retinoic acid receptor, gamma | 0.20513 | Tazarotene
 | 0.091042 | AR: androgen receptor |
| 879 | N | N | N | Chenodiol
 | RXRA: retinoid X receptor, alpha | 0.21951 | Tretinoin
 | 0.15800 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 880 | N | N | N | Bicalutamide
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.17308 | Mifepristone
 | 0.20529 | AR: androgen receptor |
| 881 | N | N | N | Mometasone furoate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.23529 | Cholecalciferol
 | 0.060029 | PGR: progesterone receptor |
| 882 | N | N | N | Dihydrotachysterol
 | RORB: RAR-related orphan receptor B | 0.34210 | Tretinoin
 | 0.16115 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 883 | N | N | N | Ethynodiol diacetate
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.12821 | Clofibrate
 | 0.092842 | ESR1: estrogen receptor 1 |
| 884 | N | N | N | Raloxifene hydrochloride
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.13043 | Phenobarbital
 | 0.13704 | ESR2: estrogen receptor 2 (ER beta) |
| 885 | N | N | N | Eplerenone
 | RXRB: retinoid X receptor, beta | 0.17021 | Tazarotene
 | 0.082031 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 886 | N | N | N | Nandrolone phenpropionate
 | RXRA: retinoid X receptor, alpha | 0.25000 | Tazarotene
 | 0.10468 | AR: androgen receptor |
| 887 | N | N | N | Dydrogesterone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.025000 | Palmitic acid
 | 0.097154 | PGR: progesterone receptor |
| 888 | N | N | N | Dienestrol
 | RORA: RAR-related orphan receptor A | 0.25265 | Imatinib mesilate
 | 0.085339 | ESR1: estrogen receptor 1 |
| 889 | N | N | N | Desogestrel
 | RARA: retinoic acid receptor, alpha | 0.12500 | Tretinoin
 | 0.14052 | ESR1: estrogen receptor 1 |
| 890 | N | N | N | Clomiphene citrate
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.15686 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
| 891 | N | N | N | Testosterone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.16216 | Tretinoin
 | 0.019212 | AR: androgen receptor |
| 892 | N | N | N | Chenodiol
 | RXRB: retinoid X receptor, beta | 0.21951 | Tretinoin
 | 0.13659 | NR1H4: nuclear receptor subfamily 1, group H, member 4 |
| 893 | N | N | N | Bicalutamide
 | RXRG: retinoid X receptor, gamma | 0.31707 | Tazarotene
 | 0.028328 | AR: androgen receptor |
| 894 | N | N | N | Estrone sodium sulfate
 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.35714 | Mifepristone
 | 0.13105 | ESR1: estrogen receptor 1 |
| 895 | N | N | N | Bicalutamide
 | RXRB: retinoid X receptor, beta | 0.31707 | Tazarotene
 | 0.093636 | AR: androgen receptor |
| 896 | N | N | N | Eplerenone
 | ESRRA: estrogen-related receptor alpha | 0.041667 | Diethylstilbestrol
 | 0.13692 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 897 | N | N | N | Nandrolone phenpropionate
 | RXRB: retinoid X receptor, beta | 0.25000 | Tazarotene
 | 0.093636 | AR: androgen receptor |
| 898 | N | N | N | Dienestrol
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.086957 | Calcitriol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 899 | N | N | N | Fluoxymesterone
 | RXRG: retinoid X receptor, gamma | 0.17949 | Tretinoin
 | 0.038684 | ESR1: estrogen receptor 1 |
| 900 | N | N | N | Flutamide
 | RXRB: retinoid X receptor, beta | 0.22222 | Tazarotene
 | 0.093636 | AR: androgen receptor |
| 901 | N | N | N | Fulvestrant
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.094340 | Phenobarbital
 | 0.13704 | ESR2: estrogen receptor 2 (ER beta) |
| 902 | N | N | N | Flutamide
 | RXRG: retinoid X receptor, gamma | 0.22222 | Tazarotene
 | 0.028328 | AR: androgen receptor |
| 903 | N | N | N | Eplerenone
 | RARB: retinoic acid receptor, beta | 0.17021 | Tazarotene
 | 0.084972 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 904 | N | N | N | Mometasone furoate
 | RXRB: retinoid X receptor, beta | 0.22449 | Tazarotene
 | 0.096643 | PGR: progesterone receptor |
| 905 | N | N | N | Levonorgestrel
 | RARA: retinoic acid receptor, alpha | 0.12500 | Tretinoin
 | 0.14052 | ESR1: estrogen receptor 1 |
| 906 | N | N | N | Norgestrel
 | RARA: retinoic acid receptor, alpha | 0.12500 | Tretinoin
 | 0.14052 | ESR1: estrogen receptor 1 |
| 907 | N | N | N | Clomiphene citrate
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.090909 | Calcitriol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 908 | N | N | N | Estrone
 | RXRA: retinoid X receptor, alpha | 0.25000 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
| 909 | N | N | N | Desogestrel
 | RORA: RAR-related orphan receptor A | 0.37838 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
| 910 | N | N | N | Cholecalciferol
 | RORC: RAR-related orphan receptor C | 0.25000 | Tretinoin
 | 0.14372 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 911 | N | N | N | Mometasone furoate
 | RXRA: retinoid X receptor, alpha | 0.22449 | Tazarotene
 | 0.10416 | PGR: progesterone receptor |
| 912 | N | N | N | Phenobarbital
 | RARG: retinoic acid receptor, gamma | 0.16667 | Tazarotene
 | 0.18237 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 913 | N | N | N | Cholesterol
 | ESRRB: estrogen-related receptor beta | 0.066667 | Diethylstilbestrol
 | 0.091736 | RORA: RAR-related orphan receptor A |
| 914 | N | N | N | Ethinyl estradiol
 | RXRA: retinoid X receptor, alpha | 0.27027 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
| 915 | N | N | N | Dienestrol
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.19355 | Phenobarbital
 | 0.12743 | ESR1: estrogen receptor 1 |
| 916 | N | N | N | Levonorgestrel
 | RARG: retinoic acid receptor, gamma | 0.12500 | Tretinoin
 | 0.14846 | ESR1: estrogen receptor 1 |
| 917 | N | N | N | Norgestrel
 | RARG: retinoic acid receptor, gamma | 0.12500 | Tretinoin
 | 0.14846 | ESR1: estrogen receptor 1 |
| 918 | N | N | N | Budesonide
 | RORC: RAR-related orphan receptor C | 0.15217 | Tretinoin
 | 0.063234 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 919 | N | N | N | Nilutamide
 | RARB: retinoic acid receptor, beta | 0.20513 | Tazarotene
 | 0.084560 | AR: androgen receptor |
| 920 | N | N | N | Butamben
 | RORB: RAR-related orphan receptor B | 0.34483 | Tazarotene
 | 0.14754 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 921 | N | N | N | Medroxyprogesterone acetate
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.36585 | Chenodiol
 | 0.077571 | PGR: progesterone receptor |
| 922 | N | N | N | Progesterone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.18421 | Tretinoin
 | 0.026027 | ESR1: estrogen receptor 1 |
| 923 | N | N | N | Eplerenone
 | RXRA: retinoid X receptor, alpha | 0.17021 | Tazarotene
 | 0.090569 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 924 | N | N | N | Cholesterol
 | ESRRA: estrogen-related receptor alpha | 0.066667 | Diethylstilbestrol
 | 0.094996 | RORA: RAR-related orphan receptor A |
| 925 | N | N | N | Nilutamide
 | ESR2: estrogen receptor 2 (ER beta) | 0.24390 | Estramustine
 | 0.11996 | AR: androgen receptor |
| 926 | N | N | N | Telmisartan
 | RXRG: retinoid X receptor, gamma | 0.23077 | Tazarotene
 | 0.029508 | PPARG: peroxisome proliferator-activated receptor gamma |
| 927 | N | N | N | Fulvestrant
 | RARA: retinoic acid receptor, alpha | 0.17857 | Tazarotene
 | 0.14896 | ESR2: estrogen receptor 2 (ER beta) |
| 928 | N | N | N | Calcitriol
 | ESRRB: estrogen-related receptor beta | 0.086957 | Diethylstilbestrol
 | 0.14119 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 929 | N | N | N | Hydrocortisone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.14286 | Tretinoin
 | 0.019114 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 930 | N | N | N | Progesterone
 | ESRRB: estrogen-related receptor beta | 0.048780 | Diethylstilbestrol
 | 0.24185 | ESR1: estrogen receptor 1 |
| 931 | N | N | N | Bicalutamide
 | NR1I3: nuclear receptor subfamily 1, group I, member 3 | 0.15000 | Phenobarbital
 | 0.087787 | AR: androgen receptor |
| 932 | N | N | N | Telmisartan
 | RXRB: retinoid X receptor, beta | 0.23077 | Tazarotene
 | 0.14366 | PPARG: peroxisome proliferator-activated receptor gamma |
| 933 | N | N | N | Norgestrel
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.30769 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 934 | N | N | N | Levonorgestrel
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.30769 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 935 | N | N | N | Estrone
 | PPARA: peroxisome proliferator-activated receptor alpha | 0.20000 | Clofibrate
 | 0.092842 | ESR1: estrogen receptor 1 |
| 936 | N | N | N | Paricalcitol
 | ESRRB: estrogen-related receptor beta | 0.086957 | Diethylstilbestrol
 | 0.14119 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 937 | N | N | N | Phenobarbital
 | RXRG: retinoid X receptor, gamma | 0.16667 | Tazarotene
 | 0.032958 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 938 | N | N | N | Dydrogesterone
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.18421 | Tretinoin
 | 0.020772 | PGR: progesterone receptor |
| 939 | N | N | N | Estrone
 | RXRB: retinoid X receptor, beta | 0.25000 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
| 940 | N | N | N | Testosterone
 | RARA: retinoic acid receptor, alpha | 0.16216 | Tretinoin
 | 0.087217 | AR: androgen receptor |
| 941 | N | N | N | Telmisartan
 | PGR: progesterone receptor | 0.14516 | Mifepristone
 | 0.069755 | PPARG: peroxisome proliferator-activated receptor gamma |
| 942 | N | N | N | Palmitic acid
 | RORB: RAR-related orphan receptor B | 0.11111 | Tretinoin
 | 0.10743 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 943 | N | N | N | Ethinyl estradiol
 | RXRB: retinoid X receptor, beta | 0.27027 | Tazarotene
 | 0.16856 | ESR1: estrogen receptor 1 |
| 944 | N | N | N | Estradiol
 | RXRG: retinoid X receptor, gamma | 0.25000 | Tazarotene
 | 0.038684 | ESR1: estrogen receptor 1 |
| 945 | N | N | N | Testosterone
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.026316 | Palmitic acid
 | 0.093100 | AR: androgen receptor |
| 946 | N | N | N | Phenobarbital
 | RARB: retinoic acid receptor, beta | 0.16667 | Tazarotene
 | 0.17553 | NR1I3: nuclear receptor subfamily 1, group I, member 3 |
| 947 | N | N | N | Oxandrolone
 | RORC: RAR-related orphan receptor C | 0.15790 | Tretinoin
 | 0.057274 | AR: androgen receptor |
| 948 | N | N | N | Flutamide
 | RARG: retinoic acid receptor, gamma | 0.22222 | Tazarotene
 | 0.091042 | AR: androgen receptor |
| 949 | N | N | N | Paricalcitol
 | ESR2: estrogen receptor 2 (ER beta) | 0.28205 | Estradiol
 | 0.10255 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 950 | N | N | N | Butamben
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.17949 | Mifepristone
 | 0.075614 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 951 | N | N | N | Levonorgestrel
 | RORB: RAR-related orphan receptor B | 0.12500 | Tretinoin
 | 0.090711 | ESR1: estrogen receptor 1 |
| 952 | N | N | N | Norgestrel
 | RORB: RAR-related orphan receptor B | 0.12500 | Tretinoin
 | 0.090711 | ESR1: estrogen receptor 1 |
| 953 | N | N | N | Bicalutamide
 | RORB: RAR-related orphan receptor B | 0.31707 | Tazarotene
 | 0.060766 | AR: androgen receptor |
| 954 | N | N | N | Isotretinoin
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.11111 | Palmitic acid
 | 0.17474 | RARA: retinoic acid receptor, alpha |
| 955 | N | N | N | Amcinonide
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.13725 | Tretinoin
 | 0.019114 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 956 | N | N | N | Amcinonide
 | RXRA: retinoid X receptor, alpha | 0.15094 | Tazarotene
 | 0.11451 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 957 | N | N | N | Spironolactone
 | RXRG: retinoid X receptor, gamma | 0.15909 | Tretinoin
 | 0.035964 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 958 | N | N | N | Bicalutamide
 | RARG: retinoic acid receptor, gamma | 0.31707 | Tazarotene
 | 0.091042 | AR: androgen receptor |
| 959 | N | N | N | Pregnenolone
 | ESR2: estrogen receptor 2 (ER beta) | 0.38710 | Estradiol
 | 0.088787 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 960 | N | N | N | Levonorgestrel
 | RARB: retinoic acid receptor, beta | 0.12500 | Tretinoin
 | 0.14884 | ESR1: estrogen receptor 1 |
| 961 | N | N | N | Norgestrel
 | RARB: retinoic acid receptor, beta | 0.12500 | Tretinoin
 | 0.14884 | ESR1: estrogen receptor 1 |
| 962 | N | N | N | Estramustine
 | RORA: RAR-related orphan receptor A | 0.28106 | Cholesterol
 | 0.088647 | ESR2: estrogen receptor 2 (ER beta) |
| 963 | N | N | N | Loteprednol etabonate
 | RORB: RAR-related orphan receptor B | 0.18750 | Tazarotene
 | 0.065341 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 964 | N | N | N | Imatinib mesilate
 | RXRB: retinoid X receptor, beta | 0.31372 | Tazarotene
 | 0.10316 | RORA: RAR-related orphan receptor A |
| 965 | N | N | N | Isotretinoin
 | NR3C2: nuclear receptor subfamily 3, group C, member 2 | 0.17391 | Mifepristone
 | 0.087093 | RARA: retinoic acid receptor, alpha |
| 966 | N | N | N | Loteprednol etabonate
 | NR0B1: nuclear receptor subfamily 0, group B, member 1 | 0.14894 | Tretinoin
 | 0.019114 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 967 | N | N | N | Raloxifene hydrochloride
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.14035 | Calcitriol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 968 | N | N | N | Nandrolone phenpropionate
 | RARG: retinoic acid receptor, gamma | 0.25000 | Tazarotene
 | 0.091042 | AR: androgen receptor |
| 969 | N | N | N | Amcinonide
 | RXRB: retinoid X receptor, beta | 0.15094 | Tazarotene
 | 0.10128 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 970 | N | N | N | Cholesterol
 | ESRRG: estrogen-related receptor gamma | 0.066667 | Diethylstilbestrol
 | 0.094696 | RORA: RAR-related orphan receptor A |
| 971 | N | N | N | Nandrolone phenpropionate
 | RORB: RAR-related orphan receptor B | 0.25000 | Tazarotene
 | 0.060766 | AR: androgen receptor |
| 972 | N | N | N | Medroxyprogesterone acetate
 | PPARG: peroxisome proliferator-activated receptor gamma | 0.070175 | Rosiglitazone maleate
 | 0.069755 | PGR: progesterone receptor |
| 973 | N | N | N | Progesterone
 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.37838 | Cholecalciferol
 | 0.11238 | ESR1: estrogen receptor 1 |
| 974 | N | N | N | Testosterone
 | RORC: RAR-related orphan receptor C | 0.16216 | Tretinoin
 | 0.057274 | AR: androgen receptor |
| 975 | N | N | N | Cholecalciferol
 | RORB: RAR-related orphan receptor B | 0.25000 | Tretinoin
 | 0.16115 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 976 | N | N | N | Nilutamide
 | ESRRA: estrogen-related receptor alpha | 0.20000 | Diethylstilbestrol
 | 0.12419 | AR: androgen receptor |
| 977 | N | N | N | Ethynodiol diacetate
 | RORC: RAR-related orphan receptor C | 0.16279 | Tretinoin
 | 0.081057 | ESR1: estrogen receptor 1 |
| 978 | N | N | N | Fenofibrate
 | RORC: RAR-related orphan receptor C | 0.093023 | Tretinoin
 | 0.14184 | PPARA: peroxisome proliferator-activated receptor alpha |
| 979 | N | N | N | Rifampin
 | RORB: RAR-related orphan receptor B | 0.16667 | Tazarotene
 | 0.14754 | NR1I2: nuclear receptor subfamily 1, group I, member 2 |
| 980 | N | N | N | Estrone sodium sulfate
 | RXRA: retinoid X receptor, alpha | 0.21951 | Tazarotene
 | 0.18294 | ESR1: estrogen receptor 1 |
| 981 | N | N | N | Palmitic acid
 | RARB: retinoic acid receptor, beta | 0.11111 | Tretinoin
 | 0.18903 | HNF4G: hepatocyte nuclear factor 4, gamma |
| 982 | N | N | N | Estrone
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.29730 | Chenodiol
 | 0.11758 | ESR1: estrogen receptor 1 |
| 983 | N | N | N | Desogestrel
 | RORB: RAR-related orphan receptor B | 0.12500 | Tretinoin
 | 0.090711 | ESR1: estrogen receptor 1 |
| 984 | N | N | N | Mometasone furoate
 | HNF4G: hepatocyte nuclear factor 4, gamma | 0.039216 | Palmitic acid
 | 0.097154 | PGR: progesterone receptor |
| 986 | N | N | N | Imatinib mesilate
 | RXRA: retinoid X receptor, alpha | 0.31372 | Tazarotene
 | 0.11627 | RORA: RAR-related orphan receptor A |
| 987 | N | N | N | Eplerenone
 | ESRRG: estrogen-related receptor gamma | 0.041667 | Diethylstilbestrol
 | 0.13025 | NR3C2: nuclear receptor subfamily 3, group C, member 2 |
| 988 | N | N | N | Flutamide
 | RARB: retinoic acid receptor, beta | 0.22222 | Tazarotene
 | 0.084560 | AR: androgen receptor |
| 990 | N | N | N | Loteprednol etabonate
 | ESRRG: estrogen-related receptor gamma | 0.083333 | Diethylstilbestrol
 | 0.16148 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 991 | N | N | N | Mometasone furoate
 | RARG: retinoic acid receptor, gamma | 0.22449 | Tazarotene
 | 0.087116 | PGR: progesterone receptor |
| 992 | N | N | N | Medroxyprogesterone acetate
 | RORB: RAR-related orphan receptor B | 0.19048 | Tretinoin
 | 0.062441 | PGR: progesterone receptor |
| 993 | N | N | N | Budesonide
 | RXRG: retinoid X receptor, gamma | 0.15217 | Tretinoin
 | 0.042474 | NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| 994 | N | N | N | Raloxifene hydrochloride
 | NR1H4: nuclear receptor subfamily 1, group H, member 4 | 0.14546 | Chenodiol
 | 0.12692 | ESR2: estrogen receptor 2 (ER beta) |
| 995 | N | N | N | Calcitriol
 | ESRRG: estrogen-related receptor gamma | 0.086957 | Diethylstilbestrol
 | 0.14277 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 996 | N | N | N | Paricalcitol
 | ESRRG: estrogen-related receptor gamma | 0.086957 | Diethylstilbestrol
 | 0.14277 | VDR: vitamin D (1,25- dihydroxyvitamin D3) receptor |
| 997 | N | N | N | Raloxifene hydrochloride
 | RXRG: retinoid X receptor, gamma | 0.30435 | Tazarotene
 | 0.038684 | ESR1: estrogen receptor 1 |
| 998 | N | N | N | Desogestrel
 | RARG: retinoic acid receptor, gamma | 0.12500 | Tretinoin
 | 0.14846 | ESR1: estrogen receptor 1 |
| 999 | N | N | N | Fluoxymesterone
 | RORA: RAR-related orphan receptor A | 0.44444 | Cholesterol
 | 0.085339 | ESR1: estrogen receptor 1 |
| 1000 | N | N | N | Cholesterol
 | RARB: retinoic acid receptor, beta | 0.19048 | Tretinoin
 | 0.17163 | RORA: RAR-related orphan receptor A |